MXPA98006317A - Production of hydroxyled fatty acids in plants genetically modifies - Google Patents
Production of hydroxyled fatty acids in plants genetically modifiesInfo
- Publication number
- MXPA98006317A MXPA98006317A MXPA/A/1998/006317A MX9806317A MXPA98006317A MX PA98006317 A MXPA98006317 A MX PA98006317A MX 9806317 A MX9806317 A MX 9806317A MX PA98006317 A MXPA98006317 A MX PA98006317A
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxylase
- fatty acid
- leu
- plant
- val
- Prior art date
Links
- 239000000194 fatty acid Substances 0.000 title claims abstract description 140
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 137
- 150000004665 fatty acids Chemical class 0.000 title claims abstract description 132
- 238000004519 manufacturing process Methods 0.000 title description 31
- 150000001413 amino acids Chemical class 0.000 claims abstract description 49
- 101700026954 FA2H Proteins 0.000 claims abstract description 20
- 102100018265 FA2H Human genes 0.000 claims abstract description 19
- 241000196324 Embryophyta Species 0.000 claims description 223
- 235000004443 Ricinus communis Nutrition 0.000 claims description 56
- 150000007523 nucleic acids Chemical class 0.000 claims description 44
- 230000000694 effects Effects 0.000 claims description 43
- 239000002253 acid Substances 0.000 claims description 41
- 241000893896 Physaria fendleri Species 0.000 claims description 32
- 108020004707 nucleic acids Proteins 0.000 claims description 28
- 239000002773 nucleotide Substances 0.000 claims description 20
- 125000003729 nucleotide group Chemical group 0.000 claims description 20
- 230000001131 transforming Effects 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 17
- 101700058125 DES Proteins 0.000 claims description 12
- 101710026007 SCD Proteins 0.000 claims description 12
- 102100016914 SCD Human genes 0.000 claims description 12
- 101710026013 SPCC1281.06c Proteins 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 11
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 11
- 240000000528 Ricinus communis Species 0.000 claims description 10
- 238000010353 genetic engineering Methods 0.000 claims description 9
- 240000007842 Glycine max Species 0.000 claims description 8
- 125000003372 histidine group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims description 8
- 235000011331 Brassica Nutrition 0.000 claims description 6
- 241000219198 Brassica Species 0.000 claims description 6
- 240000006669 Helianthus annuus Species 0.000 claims description 6
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 240000005781 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 5
- 240000005801 Carthamus tinctorius Species 0.000 claims description 5
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 5
- 240000007170 Cocos nucifera Species 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 5
- 241000219992 Cuphea Species 0.000 claims description 5
- 240000006962 Gossypium hirsutum Species 0.000 claims description 5
- 240000006240 Linum usitatissimum Species 0.000 claims description 5
- 235000004431 Linum usitatissimum Nutrition 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 235000005824 corn Nutrition 0.000 claims description 4
- 230000003247 decreasing Effects 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims 2
- 239000002540 palm oil Substances 0.000 claims 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 abstract description 38
- 229920002676 Complementary DNA Polymers 0.000 abstract description 12
- 239000002299 complementary DNA Substances 0.000 abstract description 12
- -1 lipid fatty acids Chemical class 0.000 abstract description 12
- 108010087894 Fatty Acid Desaturases Proteins 0.000 abstract description 10
- 102000009114 Fatty Acid Desaturases Human genes 0.000 abstract description 10
- 210000004027 cells Anatomy 0.000 description 56
- 230000014509 gene expression Effects 0.000 description 52
- 101700086596 CASZ1 Proteins 0.000 description 47
- 102100002568 CASZ1 Human genes 0.000 description 47
- 102000004190 Enzymes Human genes 0.000 description 44
- 108090000790 Enzymes Proteins 0.000 description 44
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 42
- 241000219194 Arabidopsis Species 0.000 description 36
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 34
- 108010051242 phenylalanylserine Proteins 0.000 description 34
- 150000002632 lipids Chemical class 0.000 description 33
- 239000000758 substrate Substances 0.000 description 33
- WBHHMMIMDMUBKC-GKUQOKNUSA-N Ricinoleic acid Natural products CCCCCC[C@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-GKUQOKNUSA-N 0.000 description 27
- 229960003656 ricinoleic acid Drugs 0.000 description 27
- 241000894007 species Species 0.000 description 27
- 210000001519 tissues Anatomy 0.000 description 27
- WBHHMMIMDMUBKC-QJWNTBNXSA-N Ricinoleic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-QJWNTBNXSA-N 0.000 description 26
- 235000001014 amino acid Nutrition 0.000 description 26
- 235000018102 proteins Nutrition 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 26
- 108090000623 proteins and genes Proteins 0.000 description 26
- ROHDXJUFQVRDAV-UWVGGRQHSA-N Phe-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ROHDXJUFQVRDAV-UWVGGRQHSA-N 0.000 description 23
- 239000000203 mixture Substances 0.000 description 23
- 230000000875 corresponding Effects 0.000 description 18
- 239000005642 Oleic acid Substances 0.000 description 17
- HPYDSVWYXXKHRD-VIFPVBQESA-N Tyr-Gly Chemical compound [O-]C(=O)CNC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 HPYDSVWYXXKHRD-VIFPVBQESA-N 0.000 description 17
- 108010028295 histidylhistidine Proteins 0.000 description 17
- 108010092114 histidylphenylalanine Proteins 0.000 description 17
- 230000004048 modification Effects 0.000 description 17
- 238000006011 modification reaction Methods 0.000 description 17
- LRKCBIUDWAXNEG-CSMHCCOUSA-N Leu-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRKCBIUDWAXNEG-CSMHCCOUSA-N 0.000 description 16
- 238000003752 polymerase chain reaction Methods 0.000 description 16
- 230000035897 transcription Effects 0.000 description 16
- 241000237955 Nassarius Species 0.000 description 15
- 241000390166 Physaria Species 0.000 description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 14
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 14
- GIAZPLMMQOERPN-YUMQZZPRSA-N Val-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GIAZPLMMQOERPN-YUMQZZPRSA-N 0.000 description 14
- MLTRLIITQPXHBJ-BQBZGAKWSA-N Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O MLTRLIITQPXHBJ-BQBZGAKWSA-N 0.000 description 13
- CGWAPUBOXJWXMS-HOTGVXAUSA-N Tyr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 CGWAPUBOXJWXMS-HOTGVXAUSA-N 0.000 description 13
- 108010068265 aspartyltyrosine Proteins 0.000 description 13
- 239000002609 media Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- WBHHMMIMDMUBKC-QJWNTBNXSA-M (Z,12R)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 12
- 241000589158 Agrobacterium Species 0.000 description 12
- JYOAXOMPIXKMKK-UHFFFAOYSA-N Leucyl-Glutamine Chemical compound CC(C)CC(N)C(=O)NC(C(O)=O)CCC(N)=O JYOAXOMPIXKMKK-UHFFFAOYSA-N 0.000 description 12
- 229940066675 Ricinoleate Drugs 0.000 description 12
- 108010050848 glycylleucine Proteins 0.000 description 12
- 108010061238 threonyl-glycine Proteins 0.000 description 12
- IJYZHIOOBGIINM-WDSKDSINSA-N Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N IJYZHIOOBGIINM-WDSKDSINSA-N 0.000 description 11
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 description 11
- OHUXOEXBXPZKPT-STQMWFEESA-N Phe-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=CC=C1 OHUXOEXBXPZKPT-STQMWFEESA-N 0.000 description 11
- 108010078144 glutaminyl-glycine Proteins 0.000 description 11
- STKYPAFSDFAEPH-LURJTMIESA-N gly-val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CN STKYPAFSDFAEPH-LURJTMIESA-N 0.000 description 11
- 108010037850 glycylvaline Proteins 0.000 description 11
- KRBMQYPTDYSENE-BQBZGAKWSA-N His-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 KRBMQYPTDYSENE-BQBZGAKWSA-N 0.000 description 10
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 10
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 10
- LWFWZRANSFAJDR-JSGCOSHPSA-N Trp-Val Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(O)=O)=CNC2=C1 LWFWZRANSFAJDR-JSGCOSHPSA-N 0.000 description 10
- ONWMQORSVZYVNH-UHFFFAOYSA-N Tyrosyl-Asparagine Chemical compound NC(=O)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 ONWMQORSVZYVNH-UHFFFAOYSA-N 0.000 description 10
- 238000009825 accumulation Methods 0.000 description 10
- 230000001965 increased Effects 0.000 description 10
- 108010057821 leucylproline Proteins 0.000 description 10
- 108010054155 lysyllysine Proteins 0.000 description 10
- 238000001819 mass spectrum Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 108010080629 tryptophan-leucine Proteins 0.000 description 10
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 description 9
- NFDYGNFETJVMSE-BQBZGAKWSA-N Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CO NFDYGNFETJVMSE-BQBZGAKWSA-N 0.000 description 9
- DXYQIGZZWYBXSD-UHFFFAOYSA-N Tryptophyl-Proline Chemical compound C=1NC2=CC=CC=C2C=1CC(N)C(=O)N1CCCC1C(O)=O DXYQIGZZWYBXSD-UHFFFAOYSA-N 0.000 description 9
- QZOSVNLXLSNHQK-UHFFFAOYSA-N Tyrosyl-Aspartate Chemical compound OC(=O)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 QZOSVNLXLSNHQK-UHFFFAOYSA-N 0.000 description 9
- GVRKWABULJAONN-UHFFFAOYSA-N Valyl-Threonine Chemical compound CC(C)C(N)C(=O)NC(C(C)O)C(O)=O GVRKWABULJAONN-UHFFFAOYSA-N 0.000 description 9
- 108010013835 arginine glutamate Proteins 0.000 description 9
- 108010038633 aspartylglutamate Proteins 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 108010090894 prolylleucine Proteins 0.000 description 9
- 230000001105 regulatory Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 108010044292 tryptophyltyrosine Proteins 0.000 description 9
- IOUPEELXVYPCPG-UHFFFAOYSA-N val-gly Chemical compound CC(C)C(N)C(=O)NCC(O)=O IOUPEELXVYPCPG-UHFFFAOYSA-N 0.000 description 9
- GWEIHUNYMRRZJJ-MOAWTDCJSA-N (11Z,17Z)-14-hydroxyicosa-11,17-dienoic acid Chemical compound CC\C=C/CCC(O)C\C=C/CCCCCCCCCC(O)=O GWEIHUNYMRRZJJ-MOAWTDCJSA-N 0.000 description 8
- XUUXCWCKKCZEAW-YFKPBYRVSA-N 2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N XUUXCWCKKCZEAW-YFKPBYRVSA-N 0.000 description 8
- JQDFGZKKXBEANU-UHFFFAOYSA-N Alanyl-Cysteine Chemical compound CC(N)C(=O)NC(CS)C(O)=O JQDFGZKKXBEANU-UHFFFAOYSA-N 0.000 description 8
- CKAJHWFHHFSCDT-WHFBIAKZSA-N Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O CKAJHWFHHFSCDT-WHFBIAKZSA-N 0.000 description 8
- 210000002472 Endoplasmic Reticulum Anatomy 0.000 description 8
- MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- HFKJBCPRWWGPEY-BQBZGAKWSA-N L-arginyl-L-glutamic acid Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HFKJBCPRWWGPEY-BQBZGAKWSA-N 0.000 description 8
- NVGBPTNZLWRQSY-UWVGGRQHSA-N Lys-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN NVGBPTNZLWRQSY-UWVGGRQHSA-N 0.000 description 8
- MYTOTTSMVMWVJN-STQMWFEESA-N Lys-Tyr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 MYTOTTSMVMWVJN-STQMWFEESA-N 0.000 description 8
- BEPSGCXDIVACBU-UHFFFAOYSA-N Prolyl-Histidine Chemical compound C1CCNC1C(=O)NC(C(=O)O)CC1=CN=CN1 BEPSGCXDIVACBU-UHFFFAOYSA-N 0.000 description 8
- 108010064997 VPY tripeptide Proteins 0.000 description 8
- WITCOKQIPFWQQD-FSPLSTOPSA-N Val-Asn Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CC(N)=O WITCOKQIPFWQQD-FSPLSTOPSA-N 0.000 description 8
- WPSXZFTVLIAPCN-UHFFFAOYSA-N Valyl-Cysteine Chemical compound CC(C)C(N)C(=O)NC(CS)C(O)=O WPSXZFTVLIAPCN-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 108010068380 arginylarginine Proteins 0.000 description 8
- 108010060035 arginylproline Proteins 0.000 description 8
- 108010077245 asparaginyl-proline Proteins 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 238000010276 construction Methods 0.000 description 8
- 230000000640 hydroxylating Effects 0.000 description 8
- 238000005805 hydroxylation reaction Methods 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 8
- 108010078580 tyrosylleucine Proteins 0.000 description 8
- 108010003137 tyrosyltyrosine Proteins 0.000 description 8
- 235000015112 vegetable and seed oil Nutrition 0.000 description 8
- MPZWMIIOPAPAKE-UHFFFAOYSA-N 4-amino-5-[[1-carboxy-4-(diaminomethylideneamino)butyl]amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(C(O)=O)CCCN=C(N)N MPZWMIIOPAPAKE-UHFFFAOYSA-N 0.000 description 7
- BUQICHWNXBIBOG-LMVFSUKVSA-N Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)N BUQICHWNXBIBOG-LMVFSUKVSA-N 0.000 description 7
- GADKFYNESXNRLC-WDSKDSINSA-N Asn-Pro Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O GADKFYNESXNRLC-WDSKDSINSA-N 0.000 description 7
- PSZNHSNIGMJYOZ-WDSKDSINSA-N Asp-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PSZNHSNIGMJYOZ-WDSKDSINSA-N 0.000 description 7
- 240000002791 Brassica napus Species 0.000 description 7
- JEFZIKRIDLHOIF-BYPYZUCNSA-N Gln-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(O)=O JEFZIKRIDLHOIF-BYPYZUCNSA-N 0.000 description 7
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 7
- DKEXFJVMVGETOO-LURJTMIESA-N Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CN DKEXFJVMVGETOO-LURJTMIESA-N 0.000 description 7
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 7
- LNCFUHAPNTYMJB-IUCAKERBSA-N His-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNCFUHAPNTYMJB-IUCAKERBSA-N 0.000 description 7
- WRPDZHJNLYNFFT-UHFFFAOYSA-N Histidinyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC1=CN=CN1 WRPDZHJNLYNFFT-UHFFFAOYSA-N 0.000 description 7
- VTJUNIYRYIAIHF-IUCAKERBSA-N Leu-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O VTJUNIYRYIAIHF-IUCAKERBSA-N 0.000 description 7
- XGDCYUQSFDQISZ-BQBZGAKWSA-N Leu-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O XGDCYUQSFDQISZ-BQBZGAKWSA-N 0.000 description 7
- LAFKUZYWNCHOHT-WHFBIAKZSA-N Ser-Glu Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O LAFKUZYWNCHOHT-WHFBIAKZSA-N 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- PEEAINPHPNDNGE-JQWIXIFHSA-N Trp-Asp Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O)=CNC2=C1 PEEAINPHPNDNGE-JQWIXIFHSA-N 0.000 description 7
- ZQOOYCZQENFIMC-STQMWFEESA-N Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=C(O)C=C1 ZQOOYCZQENFIMC-STQMWFEESA-N 0.000 description 7
- BMPPMAOOKQJYIP-WMZOPIPTSA-N Tyr-Trp Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C([O-])=O)C1=CC=C(O)C=C1 BMPPMAOOKQJYIP-WMZOPIPTSA-N 0.000 description 7
- STTYIMSDIYISRG-WDSKDSINSA-N Val-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(O)=O STTYIMSDIYISRG-WDSKDSINSA-N 0.000 description 7
- 150000007513 acids Chemical class 0.000 description 7
- 125000002252 acyl group Chemical group 0.000 description 7
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 7
- 150000002190 fatty acyls Chemical group 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 108010049041 glutamylalanine Proteins 0.000 description 7
- BITHHVVYSMSWAG-KTKRTIGZSA-N gondoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 7
- 108010085325 histidylproline Proteins 0.000 description 7
- 108010018006 histidylserine Proteins 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 108010034529 leucyl-lysine Proteins 0.000 description 7
- 108010064235 lysylglycine Proteins 0.000 description 7
- 108010044655 lysylproline Proteins 0.000 description 7
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 7
- 108010048818 seryl-histidine Proteins 0.000 description 7
- 108010084932 tryptophyl-proline Proteins 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- LQJAALCCPOTJGB-YUMQZZPRSA-N (2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxylic acid Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O LQJAALCCPOTJGB-YUMQZZPRSA-N 0.000 description 6
- QXRNAOYBCYVZCD-BQBZGAKWSA-N (2S)-6-amino-2-[[(2S)-2-aminopropanoyl]amino]hexanoic acid Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN QXRNAOYBCYVZCD-BQBZGAKWSA-N 0.000 description 6
- OKIDIWHWTIMACU-PRMNSHRPSA-N (9Z,12S,15Z)-12-hydroxyoctadeca-9,15-dienoic acid Chemical compound CC\C=C/CC[C@H](O)C\C=C/CCCCCCCC(O)=O OKIDIWHWTIMACU-PRMNSHRPSA-N 0.000 description 6
- PABVKUJVLNMOJP-UHFFFAOYSA-N 4-amino-5-[(1-carboxy-2-sulfanylethyl)amino]-5-oxopentanoic acid Chemical compound OC(=O)CCC(N)C(=O)NC(CS)C(O)=O PABVKUJVLNMOJP-UHFFFAOYSA-N 0.000 description 6
- VBKIFHUVGLOJKT-UHFFFAOYSA-N Asparaginyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC(N)=O VBKIFHUVGLOJKT-UHFFFAOYSA-N 0.000 description 6
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 6
- 229920001405 Coding region Polymers 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 6
- YIWFXZNIBQBFHR-LURJTMIESA-N Gly-His Chemical compound [NH3+]CC(=O)N[C@H](C([O-])=O)CC1=CN=CN1 YIWFXZNIBQBFHR-LURJTMIESA-N 0.000 description 6
- HTOOKGDPMXSJSY-STQMWFEESA-N His-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 HTOOKGDPMXSJSY-STQMWFEESA-N 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 6
- YQAIUOWPSUOINN-IUCAKERBSA-N Lys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN YQAIUOWPSUOINN-IUCAKERBSA-N 0.000 description 6
- QXOHLNCNYLGICT-YFKPBYRVSA-N Met-Gly Chemical compound CSCC[C@H](N)C(=O)NCC(O)=O QXOHLNCNYLGICT-YFKPBYRVSA-N 0.000 description 6
- 229940049964 Oleate Drugs 0.000 description 6
- NYQBYASWHVRESG-MIMYLULJSA-N Phe-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 NYQBYASWHVRESG-MIMYLULJSA-N 0.000 description 6
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 6
- OIDKVWTWGDWMHY-RYUDHWBXSA-N Pro-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 OIDKVWTWGDWMHY-RYUDHWBXSA-N 0.000 description 6
- XZKQVQKUZMAADP-IMJSIDKUSA-N Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(O)=O XZKQVQKUZMAADP-IMJSIDKUSA-N 0.000 description 6
- SBMNPABNWKXNBJ-UHFFFAOYSA-N Serinyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CO SBMNPABNWKXNBJ-UHFFFAOYSA-N 0.000 description 6
- LZLREEUGSYITMX-UHFFFAOYSA-N Serinyl-Tryptophan Chemical compound C1=CC=C2C(CC(NC(=O)C(CO)N)C(O)=O)=CNC2=C1 LZLREEUGSYITMX-UHFFFAOYSA-N 0.000 description 6
- IOWJRKAVLALBQB-IWGUZYHVSA-N Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O IOWJRKAVLALBQB-IWGUZYHVSA-N 0.000 description 6
- WXVIGTAUZBUDPZ-DTLFHODZSA-N Thr-His Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 WXVIGTAUZBUDPZ-DTLFHODZSA-N 0.000 description 6
- BQBCIBCLXBKYHW-CSMHCCOUSA-N Thr-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])[C@@H](C)O BQBCIBCLXBKYHW-CSMHCCOUSA-N 0.000 description 6
- APIDTRXFGYOLLH-VQVTYTSYSA-N Thr-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H](N)[C@@H](C)O APIDTRXFGYOLLH-VQVTYTSYSA-N 0.000 description 6
- CKHWEVXPLJBEOZ-UHFFFAOYSA-N Threoninyl-Valine Chemical compound CC(C)C(C(O)=O)NC(=O)C(N)C(C)O CKHWEVXPLJBEOZ-UHFFFAOYSA-N 0.000 description 6
- LYMVXFSTACVOLP-ZFWWWQNUSA-N Trp-Leu Chemical compound C1=CC=C2C(C[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C([O-])=O)=CNC2=C1 LYMVXFSTACVOLP-ZFWWWQNUSA-N 0.000 description 6
- TYYLDKGBCJGJGW-WMZOPIPTSA-N Trp-Tyr Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 TYYLDKGBCJGJGW-WMZOPIPTSA-N 0.000 description 6
- UPJONISHZRADBH-XPUUQOCRSA-N Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UPJONISHZRADBH-XPUUQOCRSA-N 0.000 description 6
- JKHXYJKMNSSFFL-IUCAKERBSA-N Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN JKHXYJKMNSSFFL-IUCAKERBSA-N 0.000 description 6
- GJNDXQBALKCYSZ-RYUDHWBXSA-N Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 GJNDXQBALKCYSZ-RYUDHWBXSA-N 0.000 description 6
- 108010047857 aspartylglycine Proteins 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108010084389 glycyltryptophan Proteins 0.000 description 6
- 230000000977 initiatory Effects 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 108010012058 leucyltyrosine Proteins 0.000 description 6
- 108010017391 lysylvaline Proteins 0.000 description 6
- 108010005942 methionylglycine Proteins 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000003228 microsomal Effects 0.000 description 6
- ZQPPMHVWECSIRJ-KTKRTIGZSA-M oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-KTKRTIGZSA-M 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 108010077112 prolyl-proline Proteins 0.000 description 6
- 230000005026 transcription initiation Effects 0.000 description 6
- 108010073969 valyllysine Proteins 0.000 description 6
- GJSURZIOUXUGAL-UHFFFAOYSA-N 2-((2,6-Dichlorophenyl)imino)imidazolidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 5
- 108010049418 Acyl Carrier Protein Proteins 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- BNODVYXZAAXSHW-UHFFFAOYSA-N Arginyl-Histidine Chemical compound NC(=N)NCCCC(N)C(=O)NC(C(O)=O)CC1=CN=CN1 BNODVYXZAAXSHW-UHFFFAOYSA-N 0.000 description 5
- RJUHZPRQRQLCFL-IMJSIDKUSA-N Asn-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(O)=O RJUHZPRQRQLCFL-IMJSIDKUSA-N 0.000 description 5
- NTQDELBZOMWXRS-UHFFFAOYSA-N Aspartyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CC(O)=O NTQDELBZOMWXRS-UHFFFAOYSA-N 0.000 description 5
- DPUOLQHDNGRHBS-KTKRTIGZSA-N Erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- BBBXWRGITSUJPB-YUMQZZPRSA-N Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O BBBXWRGITSUJPB-YUMQZZPRSA-N 0.000 description 5
- NIKBMHGRNAPJFW-UHFFFAOYSA-N Histidinyl-Arginine Chemical compound NC(=N)NCCCC(C(O)=O)NC(=O)C(N)CC1=CN=CN1 NIKBMHGRNAPJFW-UHFFFAOYSA-N 0.000 description 5
- MAJYPBAJPNUFPV-UHFFFAOYSA-N Histidinyl-Cysteine Chemical compound SCC(C(O)=O)NC(=O)C(N)CC1=CN=CN1 MAJYPBAJPNUFPV-UHFFFAOYSA-N 0.000 description 5
- JAQGKXUEKGKTKX-HOTGVXAUSA-N L-tyrosyl-L-tyrosine Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 JAQGKXUEKGKTKX-HOTGVXAUSA-N 0.000 description 5
- NFNVDJGXRFEYTK-YUMQZZPRSA-N Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O NFNVDJGXRFEYTK-YUMQZZPRSA-N 0.000 description 5
- OTXBNHIUIHNGAO-UWVGGRQHSA-N Leu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CCCCN OTXBNHIUIHNGAO-UWVGGRQHSA-N 0.000 description 5
- LHSGPCFBGJHPCY-STQMWFEESA-N Leu-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-STQMWFEESA-N 0.000 description 5
- AIXUQKMMBQJZCU-IUCAKERBSA-N Lys-Pro Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O AIXUQKMMBQJZCU-IUCAKERBSA-N 0.000 description 5
- YSZNURNVYFUEHC-BQBZGAKWSA-N Lys-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O YSZNURNVYFUEHC-BQBZGAKWSA-N 0.000 description 5
- 210000001589 Microsomes Anatomy 0.000 description 5
- BXNGIHFNNNSEOS-UWVGGRQHSA-N Phe-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 BXNGIHFNNNSEOS-UWVGGRQHSA-N 0.000 description 5
- GLUBLISJVJFHQS-VIFPVBQESA-N Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 GLUBLISJVJFHQS-VIFPVBQESA-N 0.000 description 5
- VBKBDLMWICBSCY-IMJSIDKUSA-N Ser-Asp Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O VBKBDLMWICBSCY-IMJSIDKUSA-N 0.000 description 5
- YZMPDHTZJJCGEI-BQBZGAKWSA-N Ser-His Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 YZMPDHTZJJCGEI-BQBZGAKWSA-N 0.000 description 5
- PPQRSMGDOHLTBE-UWVGGRQHSA-N Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PPQRSMGDOHLTBE-UWVGGRQHSA-N 0.000 description 5
- OYOQKMOWUDVWCR-RYUDHWBXSA-N Tyr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OYOQKMOWUDVWCR-RYUDHWBXSA-N 0.000 description 5
- ZSXJENBJGRHKIG-UHFFFAOYSA-N Tyrosyl-Serine Chemical compound OCC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 ZSXJENBJGRHKIG-UHFFFAOYSA-N 0.000 description 5
- 230000000692 anti-sense Effects 0.000 description 5
- 108090001123 antibodies Proteins 0.000 description 5
- 102000004965 antibodies Human genes 0.000 description 5
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 5
- 108010093581 aspartyl-proline Proteins 0.000 description 5
- 125000004432 carbon atoms Chemical group C* 0.000 description 5
- 108010016616 cysteinylglycine Proteins 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 108010000434 glycyl-alanyl-leucine Proteins 0.000 description 5
- 108010077515 glycylproline Proteins 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 5
- WUGMRIBZSVSJNP-UFBFGSQYSA-N Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UFBFGSQYSA-N 0.000 description 4
- 241000219195 Arabidopsis thaliana Species 0.000 description 4
- JHFNSBBHKSZXKB-VKHMYHEASA-N Asp-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(O)=O JHFNSBBHKSZXKB-VKHMYHEASA-N 0.000 description 4
- 235000011297 Brassica napobrassica Nutrition 0.000 description 4
- 235000011293 Brassica napus Nutrition 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 4
- 102000007605 Cytochromes b5 Human genes 0.000 description 4
- 108010007167 Cytochromes b5 Proteins 0.000 description 4
- JSIQVRIXMINMTA-ZDLURKLDSA-N Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O JSIQVRIXMINMTA-ZDLURKLDSA-N 0.000 description 4
- YSWHPLCDIMUKFE-QWRGUYRKSA-N Glu-Tyr Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 YSWHPLCDIMUKFE-QWRGUYRKSA-N 0.000 description 4
- OLIFSFOFKGKIRH-WUJLRWPWSA-N Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CN OLIFSFOFKGKIRH-WUJLRWPWSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 241000880493 Leptailurus serval Species 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- HGNRJCINZYHNOU-LURJTMIESA-N Lys-Gly Chemical compound NCCCC[C@H](N)C(=O)NCC(O)=O HGNRJCINZYHNOU-LURJTMIESA-N 0.000 description 4
- ADHNYKZHPOEULM-BQBZGAKWSA-N Met-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O ADHNYKZHPOEULM-BQBZGAKWSA-N 0.000 description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L MgCl2 Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 4
- 229920000272 Oligonucleotide Polymers 0.000 description 4
- HWMGTNOVUDIKRE-UWVGGRQHSA-N Phe-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 HWMGTNOVUDIKRE-UWVGGRQHSA-N 0.000 description 4
- FADYJNXDPBKVCA-UHFFFAOYSA-N Phenylalanyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 4
- 102000014961 Protein Precursors Human genes 0.000 description 4
- 108010078762 Protein Precursors Proteins 0.000 description 4
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Stearin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 4
- QOLYAJSZHIJCTO-VQVTYTSYSA-N Thr-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O QOLYAJSZHIJCTO-VQVTYTSYSA-N 0.000 description 4
- DSGIVWSDDRDJIO-ZXXMMSQZSA-N Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O DSGIVWSDDRDJIO-ZXXMMSQZSA-N 0.000 description 4
- WCRFXRIWBFRZBR-GGVZMXCHSA-N Thr-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 WCRFXRIWBFRZBR-GGVZMXCHSA-N 0.000 description 4
- UQTNIFUCMBFWEJ-UHFFFAOYSA-N Threoninyl-Asparagine Chemical compound CC(O)C(N)C(=O)NC(C(O)=O)CC(N)=O UQTNIFUCMBFWEJ-UHFFFAOYSA-N 0.000 description 4
- YKRQRPFODDJQTC-UHFFFAOYSA-N Threoninyl-Lysine Chemical compound CC(O)C(N)C(=O)NC(C(O)=O)CCCCN YKRQRPFODDJQTC-UHFFFAOYSA-N 0.000 description 4
- AUEJLPRZGVVDNU-STQMWFEESA-N Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-STQMWFEESA-N 0.000 description 4
- XXDVDTMEVBYRPK-XPUUQOCRSA-N Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O XXDVDTMEVBYRPK-XPUUQOCRSA-N 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000001580 bacterial Effects 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 108010054813 diprotin B Proteins 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 4
- 108010081551 glycylphenylalanine Proteins 0.000 description 4
- 108010040030 histidinoalanine Proteins 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 108010056582 methionylglutamic acid Proteins 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000010773 plant oil Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000006152 selective media Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000002194 synthesizing Effects 0.000 description 4
- 230000002103 transcriptional Effects 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N (Z)-Palmitoleic acid Natural products CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 3
- OMLWNBVRVJYMBQ-YUMQZZPRSA-N Arg-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O OMLWNBVRVJYMBQ-YUMQZZPRSA-N 0.000 description 3
- XTWSWDJMIKUJDQ-RYUDHWBXSA-N Arg-Tyr Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 XTWSWDJMIKUJDQ-RYUDHWBXSA-N 0.000 description 3
- FRYULLIZUDQONW-IMJSIDKUSA-N Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O FRYULLIZUDQONW-IMJSIDKUSA-N 0.000 description 3
- UKGGPJNBONZZCM-WDSKDSINSA-N Aspartyl-L-proline Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O UKGGPJNBONZZCM-WDSKDSINSA-N 0.000 description 3
- 210000000941 Bile Anatomy 0.000 description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- 235000003901 Crambe Nutrition 0.000 description 3
- 241000220246 Crambe <angiosperm> Species 0.000 description 3
- 235000011309 Crambe hispanica subsp abyssinica Nutrition 0.000 description 3
- NXTYATMDWQYLGJ-UHFFFAOYSA-N Cysteinyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CS NXTYATMDWQYLGJ-UHFFFAOYSA-N 0.000 description 3
- XZFYRXDAULDNFX-UHFFFAOYSA-N Cysteinyl-Phenylalanine Chemical compound SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 3
- OELDIVRKHTYFNG-UHFFFAOYSA-N Cysteinyl-Valine Chemical compound CC(C)C(C(O)=O)NC(=O)C(N)CS OELDIVRKHTYFNG-UHFFFAOYSA-N 0.000 description 3
- GZCGUPFRVQAUEE-KCDKBNATSA-N D-(+)-Galactose Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 3
- ARPVSMCNIDAQBO-UHFFFAOYSA-N Glutaminyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CCC(N)=O ARPVSMCNIDAQBO-UHFFFAOYSA-N 0.000 description 3
- MFBYPDKTAJXHNI-VKHMYHEASA-N Gly-Cys Chemical compound [NH3+]CC(=O)N[C@@H](CS)C([O-])=O MFBYPDKTAJXHNI-VKHMYHEASA-N 0.000 description 3
- JBCLFWXMTIKCCB-VIFPVBQESA-N Gly-Phe Chemical compound NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-VIFPVBQESA-N 0.000 description 3
- VLDVBZICYBVQHB-IUCAKERBSA-N His-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])CC1=CN=CN1 VLDVBZICYBVQHB-IUCAKERBSA-N 0.000 description 3
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 3
- JXNRXNCCROJZFB-RYUDHWBXSA-N L-tyrosyl-L-arginine Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JXNRXNCCROJZFB-RYUDHWBXSA-N 0.000 description 3
- XWOBNBRUDDUEEY-UWVGGRQHSA-N Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 XWOBNBRUDDUEEY-UWVGGRQHSA-N 0.000 description 3
- 240000008962 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 description 3
- JMCOUWKXLXDERB-WMZOPIPTSA-N Phe-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 JMCOUWKXLXDERB-WMZOPIPTSA-N 0.000 description 3
- IWIANZLCJVYEFX-RYUDHWBXSA-N Pro-Phe Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 IWIANZLCJVYEFX-RYUDHWBXSA-N 0.000 description 3
- 108010039491 Ricin Proteins 0.000 description 3
- GXDLGHLJTHMDII-WISUUJSJSA-N Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(O)=O GXDLGHLJTHMDII-WISUUJSJSA-N 0.000 description 3
- UBAQSAUDKMIEQZ-QWRGUYRKSA-N Tyr-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UBAQSAUDKMIEQZ-QWRGUYRKSA-N 0.000 description 3
- BNQVUHQWZGTIBX-IUCAKERBSA-N Val-His Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CN=CN1 BNQVUHQWZGTIBX-IUCAKERBSA-N 0.000 description 3
- VEYJKJORLPYVLO-RYUDHWBXSA-N Val-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 VEYJKJORLPYVLO-RYUDHWBXSA-N 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 108010087924 alanylproline Proteins 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 3
- 230000037348 biosynthesis Effects 0.000 description 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 229920000407 conserved sequence Polymers 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 229910001882 dioxygen Inorganic materials 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 150000002313 glycerolipids Chemical class 0.000 description 3
- 108010062266 glycyl-glycyl-argininal Proteins 0.000 description 3
- 108010089804 glycyl-threonine Proteins 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000001404 mediated Effects 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 125000004430 oxygen atoms Chemical group O* 0.000 description 3
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 3
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 3
- 108010079317 prolyl-tyrosine Proteins 0.000 description 3
- 108010053725 prolylvaline Proteins 0.000 description 3
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- NJMYZEJORPYOTO-UHFFFAOYSA-N γ-glutamyl-Proline Chemical compound NC(=O)CCC(N)C(=O)N1CCCC1C(O)=O NJMYZEJORPYOTO-UHFFFAOYSA-N 0.000 description 3
- XMAUFHMAAVTODF-STQMWFEESA-N (2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 XMAUFHMAAVTODF-STQMWFEESA-N 0.000 description 2
- LZDNBBYBDGBADK-KBPBESRZSA-N (2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-KBPBESRZSA-N 0.000 description 2
- WBHHMMIMDMUBKC-UHFFFAOYSA-N 12-hydroxyoctadec-9-enoic acid Chemical compound CCCCCCC(O)CC=CCCCCCCCC(O)=O WBHHMMIMDMUBKC-UHFFFAOYSA-N 0.000 description 2
- OONXYOAWMIVMCI-UHFFFAOYSA-N 14-hydroxyicos-11-enoic acid Chemical compound CCCCCCC(O)CC=CCCCCCCCCCC(O)=O OONXYOAWMIVMCI-UHFFFAOYSA-N 0.000 description 2
- BUXAPSQPMALTOY-UHFFFAOYSA-N 2-[(2-amino-3-sulfanylpropanoyl)amino]pentanedioic acid Chemical compound SCC(N)C(=O)NC(C(O)=O)CCC(O)=O BUXAPSQPMALTOY-UHFFFAOYSA-N 0.000 description 2
- RFCVXVPWSPOMFJ-UHFFFAOYSA-N 2-[(2-azaniumyl-3-phenylpropanoyl)amino]-4-methylpentanoate Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 RFCVXVPWSPOMFJ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 2
- XZWXFWBHYRFLEF-FSPLSTOPSA-N Ala-His Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 XZWXFWBHYRFLEF-FSPLSTOPSA-N 0.000 description 2
- 108010076441 Ala-His-His Proteins 0.000 description 2
- RDIKFPRVLJLMER-BQBZGAKWSA-N Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)N RDIKFPRVLJLMER-BQBZGAKWSA-N 0.000 description 2
- PQBHGSGQZSOLIR-RYUDHWBXSA-N Arg-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PQBHGSGQZSOLIR-RYUDHWBXSA-N 0.000 description 2
- JSLGXODUIAFWCF-UHFFFAOYSA-N Arginyl-Asparagine Chemical compound NC(N)=NCCCC(N)C(=O)NC(CC(N)=O)C(O)=O JSLGXODUIAFWCF-UHFFFAOYSA-N 0.000 description 2
- KWBQPGIYEZKDEG-FSPLSTOPSA-N Asn-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(N)=O KWBQPGIYEZKDEG-FSPLSTOPSA-N 0.000 description 2
- DWBZEJHQQIURML-IMJSIDKUSA-N Asp-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(O)=O DWBZEJHQQIURML-IMJSIDKUSA-N 0.000 description 2
- SJUXYGVRSGTPMC-UHFFFAOYSA-N Asparaginyl-Alanine Chemical compound OC(=O)C(C)NC(=O)C(N)CC(N)=O SJUXYGVRSGTPMC-UHFFFAOYSA-N 0.000 description 2
- QJMCHPGWFZZRID-UHFFFAOYSA-N Asparaginyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CC(N)=O QJMCHPGWFZZRID-UHFFFAOYSA-N 0.000 description 2
- XCOBLONWWXQEBS-KPKJPENVSA-N BSTFA Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 210000001736 Capillaries Anatomy 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 101700015998 FADD Proteins 0.000 description 2
- VHLZDSUANXBJHW-UHFFFAOYSA-N Glutaminyl-Phenylalanine Chemical compound NC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 VHLZDSUANXBJHW-UHFFFAOYSA-N 0.000 description 2
- SCCPDJAQCXWPTF-VKHMYHEASA-N Gly-Asp Chemical compound NCC(=O)N[C@H](C(O)=O)CC(O)=O SCCPDJAQCXWPTF-VKHMYHEASA-N 0.000 description 2
- IEFJWDNGDZAYNZ-BYPYZUCNSA-N Gly-Glu Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(O)=O IEFJWDNGDZAYNZ-BYPYZUCNSA-N 0.000 description 2
- AJHCSUXXECOXOY-NSHDSACASA-N Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-NSHDSACASA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- DVCSNHXRZUVYAM-BQBZGAKWSA-N Leu-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC(O)=O DVCSNHXRZUVYAM-BQBZGAKWSA-N 0.000 description 2
- NPBGTPKLVJEOBE-IUCAKERBSA-N Lys-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N NPBGTPKLVJEOBE-IUCAKERBSA-N 0.000 description 2
- ATIPDCIQTUXABX-UWVGGRQHSA-N Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCCN ATIPDCIQTUXABX-UWVGGRQHSA-N 0.000 description 2
- 108020004999 Messenger RNA Proteins 0.000 description 2
- DZMGFGQBRYWJOR-YUMQZZPRSA-N Met-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O DZMGFGQBRYWJOR-YUMQZZPRSA-N 0.000 description 2
- XYVRXLDSCKEYES-JSGCOSHPSA-N Met-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 XYVRXLDSCKEYES-JSGCOSHPSA-N 0.000 description 2
- 230000036740 Metabolism Effects 0.000 description 2
- 108010066427 N-valyltryptophan Proteins 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N Nicotinamide adenine dinucleotide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 210000003463 Organelles Anatomy 0.000 description 2
- JXWLMUIXUXLIJR-QWRGUYRKSA-N Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 JXWLMUIXUXLIJR-QWRGUYRKSA-N 0.000 description 2
- FSXRLASFHBWESK-HOTGVXAUSA-N Phe-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 FSXRLASFHBWESK-HOTGVXAUSA-N 0.000 description 2
- IEHDJWSAXBGJIP-RYUDHWBXSA-N Phe-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 IEHDJWSAXBGJIP-RYUDHWBXSA-N 0.000 description 2
- FELJDCNGZFDUNR-WDSKDSINSA-N Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FELJDCNGZFDUNR-WDSKDSINSA-N 0.000 description 2
- GVUVRRPYYDHHGK-UHFFFAOYSA-N Prolyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C1CCCN1 GVUVRRPYYDHHGK-UHFFFAOYSA-N 0.000 description 2
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 2
- FFOKMZOAVHEWET-UHFFFAOYSA-N Serinyl-Cysteine Chemical compound OCC(N)C(=O)NC(CS)C(O)=O FFOKMZOAVHEWET-UHFFFAOYSA-N 0.000 description 2
- LDEBVRIURYMKQS-UHFFFAOYSA-N Serinyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CO LDEBVRIURYMKQS-UHFFFAOYSA-N 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- IQHUITKNHOKGFC-MIMYLULJSA-N Thr-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IQHUITKNHOKGFC-MIMYLULJSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- DZHDVYLBNKMLMB-ZFWWWQNUSA-N Trp-Lys Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCCN)C(O)=O)=CNC2=C1 DZHDVYLBNKMLMB-ZFWWWQNUSA-N 0.000 description 2
- AOLHUMAVONBBEZ-STQMWFEESA-N Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AOLHUMAVONBBEZ-STQMWFEESA-N 0.000 description 2
- IBIDRSSEHFLGSD-YUMQZZPRSA-N Val-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-YUMQZZPRSA-N 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000007244 Zea mays Nutrition 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010070944 alanylhistidine Proteins 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic Effects 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 2
- 108010069495 cysteinyltyrosine Proteins 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 150000001982 diacylglycerols Chemical class 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 210000002257 embryonic structures Anatomy 0.000 description 2
- 230000002255 enzymatic Effects 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- 230000002068 genetic Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- KZNQNBZMBZJQJO-YFKPBYRVSA-N gly pro Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 2
- 108010050475 glycyl-leucyl-tyrosine Proteins 0.000 description 2
- 108010020688 glycylhistidine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 239000001963 growth media Substances 0.000 description 2
- 108010025306 histidylleucine Proteins 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000001976 improved Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 108010053037 kyotorphin Proteins 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920002106 messenger RNA Polymers 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000035786 metabolism Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 108010009977 methane monooxygenase Proteins 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 108010034507 methionyltryptophan Proteins 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- XDUHQPOXLUAVEE-BPMMELMSSA-N oleoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCC\C=C/CCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 XDUHQPOXLUAVEE-BPMMELMSSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 230000036961 partial Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 108010084572 phenylalanyl-valine Proteins 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 108010073101 phenylalanylleucine Proteins 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 230000002829 reduced Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 108091007521 restriction endonucleases Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 108010009962 valyltyrosine Proteins 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000003612 virological Effects 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- ZQFAGNFSIZZYBA-UHFFFAOYSA-N γ-glutamyl-Tryptophan Chemical compound C1=CC=C2C(CC(NC(=O)C(CCC(N)=O)N)C(O)=O)=CNC2=C1 ZQFAGNFSIZZYBA-UHFFFAOYSA-N 0.000 description 2
- GWEIHUNYMRRZJJ-RMJRDLSESA-N (11Z)-14-hydroxyicosa-11,17-dienoic acid Chemical compound CCC=CCCC(O)C\C=C/CCCCCCCCCC(O)=O GWEIHUNYMRRZJJ-RMJRDLSESA-N 0.000 description 1
- UCNNZELZXFXXJQ-BZSNNMDCSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCNNZELZXFXXJQ-BZSNNMDCSA-N 0.000 description 1
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N (2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]propanoyl]amino]butanedioic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N (2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-hydroxypropanoic acid Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- ICYRCNICGBJLGM-HJGDQZAQSA-N (2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanedioic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O ICYRCNICGBJLGM-HJGDQZAQSA-N 0.000 description 1
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
- WBHHMMIMDMUBKC-XFXZXTDPSA-N (9Z)-12-hydroxyoctadec-9-enoic acid Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-XFXZXTDPSA-N 0.000 description 1
- OONXYOAWMIVMCI-KAMYIIQDSA-N (Z)-14-hydroxyicos-11-enoic acid Chemical compound CCCCCCC(O)C\C=C/CCCCCCCCCC(O)=O OONXYOAWMIVMCI-KAMYIIQDSA-N 0.000 description 1
- ONCXFUAOAOCNRC-QZOPMXJLSA-N (Z)-docos-13-enoic acid;(Z)-octadec-9-enoic acid Chemical class CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O ONCXFUAOAOCNRC-QZOPMXJLSA-N 0.000 description 1
- JPBAMKISCJZBKR-UHFFFAOYSA-N 12-hydroxyhexadec-9-enoic acid Chemical compound CCCCC(O)CC=CCCCCCCCC(O)=O JPBAMKISCJZBKR-UHFFFAOYSA-N 0.000 description 1
- GWEIHUNYMRRZJJ-UHFFFAOYSA-N 14-hydroxyicosa-11,17-dienoic acid Chemical compound CCC=CCCC(O)CC=CCCCCCCCCCC(O)=O GWEIHUNYMRRZJJ-UHFFFAOYSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N 2-[[(2S)-2-[[(2S)-2-azaniumyl-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetate Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- 108020005345 3' Untranslated Regions Proteins 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- FHEYHADEEGTOPP-UHFFFAOYSA-N 9-hydroxyoctadec-6-enoic acid Chemical compound CCCCCCCCCC(O)CC=CCCCCC(O)=O FHEYHADEEGTOPP-UHFFFAOYSA-N 0.000 description 1
- 108091022082 Acyl transferases Proteins 0.000 description 1
- 102000019632 Acyl transferases Human genes 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Natural products NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229960000643 Adenine Drugs 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- FSHURBQASBLAPO-WDSKDSINSA-N Ala-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](C)N FSHURBQASBLAPO-WDSKDSINSA-N 0.000 description 1
- OMNVYXHOSHNURL-WPRPVWTQSA-N Ala-Phe Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OMNVYXHOSHNURL-WPRPVWTQSA-N 0.000 description 1
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 1
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 1
- SIFXMYAHXJGAFC-WDSKDSINSA-N Arg-Asp Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(O)=O SIFXMYAHXJGAFC-WDSKDSINSA-N 0.000 description 1
- PMGDADKJMCOXHX-BQBZGAKWSA-N Arg-Gln Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O PMGDADKJMCOXHX-BQBZGAKWSA-N 0.000 description 1
- JQFZHHSQMKZLRU-IUCAKERBSA-N Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N JQFZHHSQMKZLRU-IUCAKERBSA-N 0.000 description 1
- QADCERNTBWTXFV-JSGCOSHPSA-N Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCNC(N)=N)N)C(O)=O)=CNC2=C1 QADCERNTBWTXFV-JSGCOSHPSA-N 0.000 description 1
- XNSKSTRGQIPTSE-UHFFFAOYSA-N Arginyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CCCNC(N)=N XNSKSTRGQIPTSE-UHFFFAOYSA-N 0.000 description 1
- ZARXTZFGQZBYFO-JQWIXIFHSA-N Asp-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(O)=O)N)C(O)=O)=CNC2=C1 ZARXTZFGQZBYFO-JQWIXIFHSA-N 0.000 description 1
- CPMKYMGGYUFOHS-FSPLSTOPSA-N Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CC(O)=O CPMKYMGGYUFOHS-FSPLSTOPSA-N 0.000 description 1
- VGRHZPNRCLAHQA-UHFFFAOYSA-N Aspartyl-Asparagine Chemical compound OC(=O)CC(N)C(=O)NC(CC(N)=O)C(O)=O VGRHZPNRCLAHQA-UHFFFAOYSA-N 0.000 description 1
- ZVDPYSVOZFINEE-UHFFFAOYSA-N Aspartyl-Leucine Chemical compound CC(C)CC(C(O)=O)NC(=O)C(N)CC(O)=O ZVDPYSVOZFINEE-UHFFFAOYSA-N 0.000 description 1
- 206010003664 Atrial septal defect Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 235000011291 Brassica nigra Nutrition 0.000 description 1
- 240000003038 Brassica nigra Species 0.000 description 1
- 101710035229 CRD Proteins 0.000 description 1
- 101700073409 CRU1 Proteins 0.000 description 1
- 101700034335 CRUA Proteins 0.000 description 1
- 101710035319 CRURS Proteins 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 229940041514 Candida albicans extract Drugs 0.000 description 1
- 241000499489 Castor canadensis Species 0.000 description 1
- 210000003763 Chloroplasts Anatomy 0.000 description 1
- 230000036880 Cls Effects 0.000 description 1
- YHDXIZKDOIWPBW-UHFFFAOYSA-N Cysteinyl-Glutamine Chemical compound SCC(N)C(=O)NC(C(O)=O)CCC(N)=O YHDXIZKDOIWPBW-UHFFFAOYSA-N 0.000 description 1
- LMKYZBGVKHTLTN-NKWVEPMBSA-N D-nopaline Chemical compound NC(=N)NCCC[C@@H](C(O)=O)N[C@@H](C(O)=O)CCC(O)=O LMKYZBGVKHTLTN-NKWVEPMBSA-N 0.000 description 1
- 229960000633 Dextran Sulfate Drugs 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N Docosahexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 108010018089 EC 1.14.18.4 Proteins 0.000 description 1
- 102000002148 EC 2.3.1.20 Human genes 0.000 description 1
- 108010001348 EC 2.3.1.20 Proteins 0.000 description 1
- 101710042240 GLUL Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- OWOFCNWTMWOOJJ-WDSKDSINSA-N Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O OWOFCNWTMWOOJJ-WDSKDSINSA-N 0.000 description 1
- LSPKYLAFTPBWIL-BYPYZUCNSA-N Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(O)=O LSPKYLAFTPBWIL-BYPYZUCNSA-N 0.000 description 1
- YBAFDPFAUTYYRW-YUMQZZPRSA-N Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O YBAFDPFAUTYYRW-YUMQZZPRSA-N 0.000 description 1
- UQHGAYSULGRWRG-WHFBIAKZSA-N Glu-Ser Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CO)C(O)=O UQHGAYSULGRWRG-WHFBIAKZSA-N 0.000 description 1
- LLEUXCDZPQOJMY-AAEUAGOBSA-N Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(O)=O)=CNC2=C1 LLEUXCDZPQOJMY-AAEUAGOBSA-N 0.000 description 1
- CLSDNFWKGFJIBZ-UHFFFAOYSA-N Glutaminyl-Lysine Chemical compound NCCCCC(C(O)=O)NC(=O)C(N)CCC(N)=O CLSDNFWKGFJIBZ-UHFFFAOYSA-N 0.000 description 1
- HHSJMSCOLJVTCX-UHFFFAOYSA-N Glutaminyl-Threonine Chemical compound CC(O)C(C(O)=O)NC(=O)C(N)CCC(N)=O HHSJMSCOLJVTCX-UHFFFAOYSA-N 0.000 description 1
- MRVYVEQPNDSWLH-UHFFFAOYSA-N Glutaminyl-Valine Chemical compound CC(C)C(C(O)=O)NC(=O)C(N)CCC(N)=O MRVYVEQPNDSWLH-UHFFFAOYSA-N 0.000 description 1
- IKAIKUBBJHFNBZ-LURJTMIESA-N Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CN IKAIKUBBJHFNBZ-LURJTMIESA-N 0.000 description 1
- PFMUCCYYAAFKTH-YFKPBYRVSA-N Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CN PFMUCCYYAAFKTH-YFKPBYRVSA-N 0.000 description 1
- 108010088778 Glycine max beta-conglycinin protein Proteins 0.000 description 1
- 101700009603 HIS3 Proteins 0.000 description 1
- MDCTVRUPVLZSPG-BQBZGAKWSA-N His-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CNC=N1 MDCTVRUPVLZSPG-BQBZGAKWSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ZUKPVRWZDMRIEO-VKHMYHEASA-N L-cysteinylglycine zwitterion Chemical compound SC[C@H]([NH3+])C(=O)NCC([O-])=O ZUKPVRWZDMRIEO-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- RNKSNIBMTUYWSH-YFKPBYRVSA-N L-prolylglycine Chemical compound [O-]C(=O)CNC(=O)[C@@H]1CCC[NH2+]1 RNKSNIBMTUYWSH-YFKPBYRVSA-N 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 229920001320 Leader sequence (mRNA) Polymers 0.000 description 1
- HIZYETOZLYFUFF-BQBZGAKWSA-N Leu-Cys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(O)=O HIZYETOZLYFUFF-BQBZGAKWSA-N 0.000 description 1
- KFKWRHQBZQICHA-STQMWFEESA-N Leu-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 1
- BQVUABVGYYSDCJ-ZFWWWQNUSA-N Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-ZFWWWQNUSA-N 0.000 description 1
- 241000208204 Linum Species 0.000 description 1
- 241000195947 Lycopodium Species 0.000 description 1
- UGTZHPSKYRIGRJ-YUMQZZPRSA-N Lys-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UGTZHPSKYRIGRJ-YUMQZZPRSA-N 0.000 description 1
- RVKIPWVMZANZLI-ZFWWWQNUSA-N Lys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-ZFWWWQNUSA-N 0.000 description 1
- IGRMTQMIDNDFAA-UHFFFAOYSA-N Lysyl-Histidine Chemical compound NCCCCC(N)C(=O)NC(C(O)=O)CC1=CN=CN1 IGRMTQMIDNDFAA-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- UASDAHIAHBRZQV-YUMQZZPRSA-N Met-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCCNC(N)=N UASDAHIAHBRZQV-YUMQZZPRSA-N 0.000 description 1
- MUMXFARPYQTTSL-BQBZGAKWSA-N Met-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O MUMXFARPYQTTSL-BQBZGAKWSA-N 0.000 description 1
- WEDDFMCSUNNZJR-WDSKDSINSA-N Met-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(O)=O WEDDFMCSUNNZJR-WDSKDSINSA-N 0.000 description 1
- KAKJTZWHIUWTTD-VQVTYTSYSA-N Met-Thr Chemical compound CSCC[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)O)C([O-])=O KAKJTZWHIUWTTD-VQVTYTSYSA-N 0.000 description 1
- PESQCPHRXOFIPX-RYUDHWBXSA-N Met-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-RYUDHWBXSA-N 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 1
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 1
- 229940052665 NADH Drugs 0.000 description 1
- 229920002332 Noncoding DNA Polymers 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 101710026527 OLE Proteins 0.000 description 1
- 101700074785 OLEO Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 101700032936 PRK2 Proteins 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000390152 Paysonia densipila Species 0.000 description 1
- MIDZLCFIAINOQN-WPRPVWTQSA-N Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 MIDZLCFIAINOQN-WPRPVWTQSA-N 0.000 description 1
- OZILORBBPKKGRI-RYUDHWBXSA-N Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 OZILORBBPKKGRI-RYUDHWBXSA-N 0.000 description 1
- WEQJQNWXCSUVMA-RYUDHWBXSA-N Phe-Pro Chemical compound C([C@H]([NH3+])C(=O)N1[C@@H](CCC1)C([O-])=O)C1=CC=CC=C1 WEQJQNWXCSUVMA-RYUDHWBXSA-N 0.000 description 1
- KNPVDQMEHSCAGX-UHFFFAOYSA-N Phenylalanyl-Cysteine Chemical compound SCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 KNPVDQMEHSCAGX-UHFFFAOYSA-N 0.000 description 1
- KLAONOISLHWJEE-UHFFFAOYSA-N Phenylalanyl-Glutamine Chemical compound NC(=O)CCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 KLAONOISLHWJEE-UHFFFAOYSA-N 0.000 description 1
- 108010079590 Phosphatidylcholine desaturase Proteins 0.000 description 1
- HMNSRTLZAJHSIK-YUMQZZPRSA-N Pro-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 HMNSRTLZAJHSIK-YUMQZZPRSA-N 0.000 description 1
- SHAQGFGGJSLLHE-BQBZGAKWSA-N Pro-Gln Chemical compound NC(=O)CC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 SHAQGFGGJSLLHE-BQBZGAKWSA-N 0.000 description 1
- RVQDZELMXZRSSI-IUCAKERBSA-N Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 RVQDZELMXZRSSI-IUCAKERBSA-N 0.000 description 1
- AFWBWPCXSWUCLB-WDSKDSINSA-N Pro-Ser Chemical compound OC[C@@H](C([O-])=O)NC(=O)[C@@H]1CCC[NH2+]1 AFWBWPCXSWUCLB-WDSKDSINSA-N 0.000 description 1
- UEKYKRQIAQHOOZ-KBPBESRZSA-N Pro-Trp Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)[O-])C(=O)[C@@H]1CCC[NH2+]1 UEKYKRQIAQHOOZ-KBPBESRZSA-N 0.000 description 1
- HXNYBZQLBWIADP-UHFFFAOYSA-N Prolyl-Cysteine Chemical compound OC(=O)C(CS)NC(=O)C1CCCN1 HXNYBZQLBWIADP-UHFFFAOYSA-N 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N RIFAMPICIN Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229940081190 Rifampin Drugs 0.000 description 1
- 101710028729 SLC25A20 Proteins 0.000 description 1
- 102100011103 SLC25A20 Human genes 0.000 description 1
- 235000003534 Saccharomyces carlsbergensis Nutrition 0.000 description 1
- 229940081969 Saccharomyces cerevisiae Drugs 0.000 description 1
- SSJMZMUVNKEENT-IMJSIDKUSA-N Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CO SSJMZMUVNKEENT-IMJSIDKUSA-N 0.000 description 1
- WBAXJMCUFIXCNI-WDSKDSINSA-N Ser-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WBAXJMCUFIXCNI-WDSKDSINSA-N 0.000 description 1
- ILVGMCVCQBJPSH-WDSKDSINSA-N Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CO ILVGMCVCQBJPSH-WDSKDSINSA-N 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229920000978 Start codon Polymers 0.000 description 1
- 240000006531 Strophanthus gratus Species 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfizole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- BWUHENPAEMNGQJ-ZDLURKLDSA-N Thr-Gln Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O BWUHENPAEMNGQJ-ZDLURKLDSA-N 0.000 description 1
- BECPPKYKPSRKCP-ZDLURKLDSA-N Thr-Glu Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O BECPPKYKPSRKCP-ZDLURKLDSA-N 0.000 description 1
- BIYXEUAFGLTAEM-WUJLRWPWSA-N Thr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(O)=O BIYXEUAFGLTAEM-WUJLRWPWSA-N 0.000 description 1
- KAFKKRJQHOECGW-JCOFBHIZSA-N Thr-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(O)=O)=CNC2=C1 KAFKKRJQHOECGW-JCOFBHIZSA-N 0.000 description 1
- 229920000401 Three prime untranslated region Polymers 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- LCPVBXOHXMBLFW-JSGCOSHPSA-N Trp-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)=CNC2=C1 LCPVBXOHXMBLFW-JSGCOSHPSA-N 0.000 description 1
- IMMPMHKLUUZKAZ-WMZOPIPTSA-N Trp-Phe Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=CC=C1 IMMPMHKLUUZKAZ-WMZOPIPTSA-N 0.000 description 1
- 101710042194 Trpgamma Proteins 0.000 description 1
- 229960004799 Tryptophan Drugs 0.000 description 1
- 241000625014 Vir Species 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- BHVZCCKRRPYXCV-MGNVXPIMSA-J [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-[(Z,12R)-12-hydroxyoctadec-9-enoyl]sulfanylethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate Chemical compound O[C@@H]1[C@H](OP([O-])([O-])=O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 BHVZCCKRRPYXCV-MGNVXPIMSA-J 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 230000002009 allergen Effects 0.000 description 1
- 108010045514 alpha-lactorphin Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000003466 anti-cipated Effects 0.000 description 1
- 229940053200 antiepileptics Fatty acid derivatives Drugs 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010091092 arginyl-glycyl-proline Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010036533 arginylvaline Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000002759 chromosomal Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000010192 crystallographic characterization Methods 0.000 description 1
- 239000002254 cytotoxic agent Substances 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 230000001809 detectable Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 230000002349 favourable Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010359 gene isolation Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 101710017807 his-44 Proteins 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 108010030617 leucyl-phenylalanyl-valine Proteins 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 101700072735 lys-1 Proteins 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 108010016686 methionyl-alanyl-serine Proteins 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 108010064486 phenylalanyl-leucyl-valine Proteins 0.000 description 1
- 108010024607 phenylalanylalanine Proteins 0.000 description 1
- 150000008103 phosphatidic acids Chemical class 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 108091008117 polyclonal antibodies Proteins 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- QLROSWPKSBORFJ-BQBZGAKWSA-N pro glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 QLROSWPKSBORFJ-BQBZGAKWSA-N 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010070643 prolylglutamic acid Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000003252 repetitive Effects 0.000 description 1
- 230000000754 repressing Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- PETSAYFQSGAEQY-UHFFFAOYSA-N ricinine Chemical class COC=1C=CN(C)C(=O)C=1C#N PETSAYFQSGAEQY-UHFFFAOYSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 230000005562 seed maturation Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000007858 starting material Chemical class 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000004642 transportation engineering Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 101710042243 trpE(G) Proteins 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Abstract
This invention relates to fatty acid-plant doroxylases. Methods for using conserved amino acid or nucleotide sequences to obtain plant fatty acid-hydroxylases are described. The use of cDNA clones encoding a plant hydroxylase to produce a family of hydroxylated fatty acids in transgenic plants is also described. In addition, the use of genes coding for fatty acid-hydroxylases or desaturases to alter the level of unsaturation of lipid fatty acids in transgenic plants is described
Description
PRODUCTION OF HYDROXYLED FATTY ACIDS IN GENETICALLY MODIFIED PLANTS
TECHNICAL FIELD.
The present invention relates to the identification of nucleic acid sequences, and constructions, and to methods related thereto and to the use of these sequences and constructions to produce genetically modified plants for the purpose of altering the composition of the fatty acids of the oils , waxes and related compounds of plants.
DEFINITIONS
The subject of the invention is a class of enzymes that introduce a hydroxyl group into several different fatty acids resulting in the production of several different classes of hydroxylated fatty acids. In particular, these enzymes catalyze the hydroxylation of oleic acid to 12-hydroxy-oleic acid and icosenoic acid to 14-hydroxy-icosoic acid. Other fatty acids such as palmitoleic acids and fatty acids can also be substrates.
REF .: 28032">
erucic Since it is not possible to refer to the enzyme by reference to a single substrate or product, the enzyme refers to the entire length as the kappa-hydroxylase to indicate that the enzyme introduces the hydroxyl, three distant carbons (ie, far of the carboxyl-carbon of the chain to the acyl) of a double bond located near the center of the acyl chain. The following fatty acids are also the
object of this invention: ricinoleic acid, acid
12-hydroxyoctadec-cis-9-enoic (120H-18: cls? S); Lesqueroic acid, 14-hydroxy-cis-ll-icosenoic acid
(14OH-20: lcls? L1); Densipolic acid, 12-hydroxyoctadec-cis-9-15-dienoic acid (120H-18: 2cls? 9'15);
auricolic acid, 14-hydroxy-cis-ll, 17-icosadienoic acid (14OH-20: 2clsAl1'17); hydroxierucic acid, 16-hydrodoxicos-cis-12-enoic acid (160H-22: 1C1S 13); hydroxypical itoleic acid, 12-hydroxyhexadec cis-9-enoic acid (120H-16: lcls? 9); icosoic acid
(20: lcls? L1). It will be noted that icosenoic acid is spelled eicosenoic in some countries.
BACKGROUND
Extensive studies of the fatty acid composition of seed oils from different species of higher plants have resulted in the identification of at least 33 plant-derived, monohydroxylated, structurally distinct, and 12 different polyhydroxy fatty acids that are accumulate by one or more plant species (reviewed by van de Loo et al., 1993). Ricinoleic acid, and its main constituent of seed oil from the ricin plant, Ricinus communis (L.), is of commercial importance. A gene has been cloned from that species encoding a fatty acid-hydroxylase, and this gene has been used to produce ricinoleic acid in transgenic plants of other species. Some of this scientific evidence has been published by the present inventors (van de Loo et al., 1995). The use of the castor hydroxylase gene or to also produce other hydroxylated fatty acids such as lesquerólico acid, densipólico acid, hidroxipalmitoleico acid, hidroxierucico, and auricólico, in transgenic plants that is the subject of this invention.
In addition, the identification of a gene encoding a homologous hydroxylase from Lesquerella fendleri, and the use of this gene to produce these hydroxylated fatty acids in transgenic plants is the subject of this invention. Castor is a minor crop of oil seeds. Approximately 50% of the weight of the seed is oil (triacylglycerol) in which 85-90% of the total fatty acids are the hydroxylated fatty acid, ricinoleic acid. The pressed oil extracted from the castor beans has many industrial uses based on the properties provided by the hydroxylated fatty acid. The most important uses are the production of paints and varnishes, synthetic nylon-type polymers, resins, lubricants, and cosmetics (Ats on, 1989). In addition to oil, castor bean contains extremely toxic protein ricin, allergenic proteins, and the ricinin alkaloid. These constituents prevent the use of untreated seed food (after oil extraction) as a livestock feed, usually an important economic aspect of the use of oil seeds. In addition, with the variable nature of castor plants and a lack of investment in reproduction, castor beans have few favorable agronomic characteristics. For a combination of these reasons, castor bean is not grown any longer in the United States and the development of an alternative national source of hydroxylated fatty acids would be attractive. The production of ricinoleic acid, the important constituent of castor oil, in the cultivation of oilseed, established through genetic engineering would be a particularly effective means of creating a national source. Because there is no practical source of lesquerólico, densipólico, and auricólico acids from plants that adapt to the practices of modern agriculture, there is currently no large-scale use of these fatty acids by industry. However, fatty acids would have uses similar to those of ricinoleic acid if they could be produced in large quantities at a cost comparable to other fatty acids derived from plants (Smith, 1985). Plant species, such as certain species in the genus Lesquerella, which accumulate a high proportion of these fatty acids, have not been domesticated and are not commonly considered a practical source of fatty acids (Hirsinger, 1989). This invention represents a useful step towards the eventual production of these and other hydroxylated fatty acids in transgenic plants of agronomic importance. Taxonomic relationships between plants that have similar or identical classes of unusual fatty acids have been examined (van de Loo et al., 1993). In some cases, particular fatty acids occur mainly or only in related taxa. In other cases, there does not seem to be a direct link between taxonomic relationships and the occurrence of unusual fatty acids. In this regard, ricinoleic acid has now been identified in 12 genera of 10 families
(reviewed in van de Loo et al., 1993). In this way, it seems that the ability to synthesize hydroxylated fatty acids has evolved several times independently during the radiation of angiosperms. This suggests that enzymes that introduce hydroxyl groups into fatty acids arise from minor modifications of the related enzyme. In fact, as shown herein, the sequence similarity between the 12 fatty acid-desaturases and the kappa-hydroxylase of the castor is high, so that it is not possible to determine inaccessibly whether a particular enzyme is a desaturase or a hydroxylase based on the evidence in the scientific literature. Similarly, a patent application (PCT WO 94/11516) which aims to teach the isolation and use of the 12 fatty acid desaturases does not teach how to distinguish a hydroxylase from a desaturase. In view of the importance of being able to distinguish between these activities for the purpose of genetic engineering of plant oils, the utility of this application is limited to the several cases where direct experimental evidence was presented (for example, altered composition of fatty acids in transgenic plants) to support the assignment of function. A method for distinguishing between fatty acid-desaturases and hydroxylases of fatty acids based on the amino acid sequence of the enzyme is also a subject of this invention. A characteristic of hydroxylated or other unusual fatty acids is that they are generally confined to seed triacylglycerols, which are largely excluded from the polar lipids of unknown mechanisms (Battey and Ohlrogge 1989;
Prasad et al., 1987). This is particularly intriguing since triacylglycerol is a precursor of both triacylglycerol and polar lipid. With castor microsomes, there is some evidence that the mixture of polar lipid containing ricinonoleoyl is minimized by a preference of diacylglycerol acyltransferase for diacylglycerols containing ricinoleate (Bafor et al., 1991). Analyzes of vegetative tissues have generated few supports of unusual fatty acids, different from those that occur in the cuticle. The cuticle contains several hydroxylated fatty acids that are inter-esterified to produce a high molecular weight polyester that serves as a structural paper. A small number of other exceptions exist in which the unusual fatty acids are found in tissues other than the seed. The biosynthesis of ricinoleic acid of oleic acid in the endosperm in development of the castor
(Ricinus communis) has been studied by a variety of methods. Morris (1967) established double-label studies that hydroxylation occurs directly by hydroxyl substitution in. place of keto- or epoxy-intermediate, or unsaturated intermediate. Hydroxylation using oleoyl-CoA as a precursor can be demonstrated in crude preparations or microsomes, but the activity of the microsomes is unstable and variable, and the isolation of the microsomes comprised a considerable, or sometimes complete, loss of activity (Galliard et al. Stumpf, 1966; Moreau and Stumpf, 1981). Oleic acid can replace oleoyl-CoA as a precursor, but only in the presence of CoA, Mg2 and ATP (Galliard and Stumpf, 1966) indicating that activation of acyl-CoA is necessary. However, radioactivity could not be detected in ricinoleoyl-CoA (Moreau and Stumpf, 1981). These observations and some more recent ones (Bafor et al., 1991) have been interpreted as evidence that the substrate for castor hydroxylase oleate is oleic acid esterified to phosphatidylcholine or another phospholipid. Hydroxylase is sensitive to cyanide and azide, and dialysis against metallic chelating agents reduces activity, which is restored by the addition of FeS0, suggesting the involvement of iron in enzymatic activity (Galliard and Stumpf, 1966). The synthesis of ricinoleic acid requires molecular oxygen (Galliard and Stumpf, 1966; Moreau and Stumpf, 1981) and requires NAD (P) H to reduce cytochrome b5, which is taught to be the intermediate electron donor for the hydroxylase reaction (Smith et al. 1992). Carbon monoxide does not inhibit hydroxylation, indicating that a cytochrome P450 is not included (Galliard and Stumpf, 1966, Moreau and Stumpf, 1981). The data from a hydroxylase substrate specificity study show that all substrate parameters (ie, chain length and double bond position with respect to both ends) are important, deviations in those parameters caused activity reduced in relation to oleic acid (Howling et al., 1972). The position at which hydroxyl was introduced, however, was determined by the position of the double bond, provided there are three distant carbons. In this way, the ricin acyl hydroxylase enzyme can produce a family of different hydroxylated fatty acids depending on the availability of the substrates. Thus, as a matter of convenience, the enzyme refers to the entire length of this specification as a kappa-hydroxylase (instead of an oleate-hydroxylase) to indicate the broad specificity of the substrate.
Castor kappa-hydroxylase has many superficial similarities to acyl-desaturases, fats, microsomes (Browse and Somerville, 1991). In particular, the plants have a microsomal oleate-desaturase activity in the • position? The substrate of this enzyme (Schmidt et al., 1993) and hydroxylase (Bafor et al., 1991) appears to be a gray acid in the sn-2 position of phosphatidylcholine. When the oleate is the substrate, the modification occurs in the same position
(? 12) in the carbon chain, and requires the same co-factors, specifically the electrons of NADH via cytochrome b5 and molecular oxygen. No enzyme is inhibited by carbon monoxide (Moreau and Stumpf, 1981), the characteristic inhibitor of cytochrome P450 enzymes. No biotechnical studies of the properties of the enzyme (s) hydroxylase in Lesquerella appear to have been published.
Conceptual basis of the invention
The use of a cDNA clone from the castor has been described herein for the production of ricinoleic acid in transgenic plants. As noted above, biochemical studies have suggested that castor hydroxylase may not have strict specificity for oleic acid but will also catalyze the hydroxylation of other fatty acids such as icosenoic acid (20: lcls? L1) (Ho ling et al. 1972). Based on these studies, the expression of kappa-hydroxylase in transgenic plants of species such as Brassica napus and Arabidopsis thaliana that accumulate fatty acids such as icosenoic acid (20: lcls? L1) and erucic acid (13-docosenoic acid; : lcls? l3) can cause the accumulation of hydroxylated derivatives of these fatty acids due to the activity of hydroxylase in these fatty acids. Direct evidence is presented in Example 1 that hydroxylated derivatives of ricinoleic, lesqueroic, densipolic and auricolic fatty acids are produced in transgenic Arabidopsis plants. Example 2 shows the isolation of a new kappa-hydroxylase gene from Lesquerella fendleri. In view of the high degree of sequence similarity between the? 2 fatty acid-desaturases and the castor hydroxylase (van de Loo et al., 1995), the validity of the claims (eg, PCT WO 94/11516) for using a limited set of desaturase or hydroxylase genes or sequences derived from them to identify genes of identical functions from other species should be viewed with skepticism. In this application, a method is taught by which the hydroxylase genes should be distinguished from the desaturases. A mechanistic basis for the similar reaction mechanisms of desaturases and hydroxylases is described. Briefly, the available evidence suggests that fatty acid-desaturases have a reaction mechanism similar to the bacterial enzyme methane-monooxygenase that catalyzes a reaction comprising the transfer of oxygen atoms (CH4 - * > CH3OH) (van de Loo and collaborators, 1993). The cofactor in the hydroxylase component of methane-monooxygenase is called a di-iron cluster, with μ-oxo bridge (FeOFe). The two iron atoms of the FeOFe group are linked by the nitrogen or oxygen atoms, derived from the protein, and are firmly coupled by the covalent binding oxygen atom. The FeOFe grouping accepts two electrons, reducing to the deferred state, before the union of the oxygen. In oxygen binding, it is likely that heterolitic cleavage also occurs, leading to a high valence oxohier reactive species that is stabilized by possible resonance rearrangements within the tightly coupled FeOFe cluster. The oxygen state, high valence, stabilized methane-oxygenase is capable of extracting protons from methane, followed by oxygen transfer, giving methanol. The cofactor FeOFe has been shown to be directly relevant to fatty acid modifications of plants by the demonstration that castor-stearoyl-ACP-desaturase contains this type of cofactor (Fox et al., 1993). Based on the above considerations, it has been suggested that castor oleate hydroxylase may be an acyl-desaturase, fat, structurally modified, based on three arguments. The first argument comprises the taxonomic distribution of plants containing ricinoleic acid. Ricinoleic acid has been found in 12 genera of 10 higher plant families (reviewed in van de Loo et al., 1993). In this way, plants in which ricinoleic acid is present are found throughout the plant kingdom, even close relationships to these plants do not contain the unusual fatty acid. This pattern suggests that the ability to synthesize ricinoleic acid has appeared (and has been lost, several times) independently, and therefore, has diverged recently. In other words, the ability to synthesize ricinoleic acid has appeared rapidly, suggesting that a relatively minor genetic change in the structure of the ancestral enzyme was necessary to achieve it. The second argument is that many biochemical properties of castor kappa-hydroxylase are similar to those of microsomal desaturases, as discussed above (for example, both act preferentially on fatty acids esterified to the sn-2 position of phosphatidylcholine, both use cytochrome b5 as an intermediate donor, both are inhibited by cyanide, both require molecular oxygen as a substrate, both are thought to be located in the endoplasmic reticulum). The third argument comes from the discussion of the previous oxygenase cofactors, in which it is suggested that the fatty acid-desaturases attached to the membrane of the plant may have a cofactor-type cluster dihierro bridge bridged by μ-oxo bridge, and that these cofactors are able to catalyze both fatty acid desaturations and hydroxylations, depending on the electronic properties and properties of the active site of the protein. Taking these three arguments together, it is suggested that the kappa-hydroxylase from the castor endosperm is homologous to the microsomal oleate-γ2-desaturase, found in all plants. A number of genes encoding microsomal? 12 from several species have recently been cloned (Okuley et al., 1994) and substantial information about the structure of these enzymes is now known (Shanklin et al., 1994). Therefore, in the following invention, it is taught how to use the structural information to isolate and identify the kappa-hydroxylase genes. This example teaches the method by which any acyl hydroxylase gene, fat, from plants insensitive to carbon monoxide, can be identified by one skilled in the art. An unexpected result of the studies on the castor hydroxylase gene in the transgenic Arabidopsis plants was the discovery that the expression of the hydroxylase leads to the increased accumulation of oleic acid in the lipids of the seed. Due to the low homology of the nucleotide sequence between the castor hydroxylase and the? 2-desaturase (approximately 67%), this effect is unlikely to be due to the deletion (also called homosense deletion or co-suppression) of the expression of the desaturase gene by the hydroxylase gene. Whatever the basis for the effect, this invention teaches the use of the hydroxylase genes to alter the level of fatty acid unsaturation in transgenic plants. this invention also teaches the use of genes of hydroxylase and desaturase, genetically modified, to achieve direct modification of the levels of unsaturation of fatty acids.
BRIEF DESCRIPTION OF THE DRAWINGS
Figures 1A-D show the mass spectra of the hydroxy fatty acid standards (Figure IA, O-TMS-methylricinoleate, Figure IB, O-TMS-methyl-densipolylate, Figure IC, O-TMS-methyl-leskoleate; and Figure ID, O-TMS-methylauricoleate).
Figure 2 shows the fragmentation pattern of the trimethylsilylated methyl esters of the hydroxy fatty acids.
Figure 3A shows the gas chromatogram of the fatty acids extracted from seeds of the wild type Arabidopsis plants. Figure 3B shows the gas chromatogram of the fatty acids extracted from the seeds of the transgenic Arabidopsis plants containing the fahl2-hydroxylase gene. The numbers indicate the following fatty acids: [1] 16: 0; [2] 18: 0; [3] 18: lcis? 9; [4] 18.2c1S? 9.i2. [5] 20: 0; [6] 20: lcls? L1; [7] 18: 3cis? 9 '? 1E; [8] 20: 2casA11'14; [9] 22: lcls? L3; [10] ricinoleic acid; [11] densipolic acid; [12] lesqueroic acid; and [13] auricolic acid.
Figures 4A-D show the mass spectra of the new fatty acids found in the seeds of the transgenic plants. Figure 4A shows the mass spectrum of peak 10 of Figure 3A. Figure 4B shows the mass spectrum of peak 11 from Figure 3B. Figure 4C shows the mass spectrum of the spectrum 12 from Figure 3B. Figure 4D shows the mass spectrum of peak 13 from Figure 3B.
Figure 5 shows the nucleotide sequence of pLesq2 (SEQ ID NO: 1).
Figure 6 shows the nucleotide sequence of pLesq3 (SEQ ID NO: 2).
Figure 7 shows a transfer
Northern of the total RNA from L. fendleri seeds probed with pLesq2 or pLesq3. S, indicates that RNA is from seeds; L, indicates that the RNA is from the leaves.
Figures 8A-B show the nucleotide sequence of the genomic clone encoding pLesq-HYD (SEQ ID NO: 3), and the deduced amino acid sequence of the hydroxylase enzyme encoded by the gene (SEQ ID NO: 4).
Figures 9A-B show the alignment of multiple sequences of deduced amino acid sequences for microscopic kappa-hydroxylases and l-2-desaturases. The abbreviations are: Rcfahl2, fahl2-hydroxylase gene from R. communis (van de Loo et al., 1995); Lffahl2, kappa-hydroxylase gene from L. fendleri; Atfad2, fad2-desaturase from Arabidopsis thaliana (Okuley et al., 1994); Gmfad2-1, fad2-desaturase from Glycine max (GenBank accession number L43920); Gmfad2-2, fad2-desaturase from Glycine max (Genbank accession number L43921); Zmfad2, fad2 desaturase from Zea mays (PCT WO 94/11516); Rcfad2, fad2-desaturase fragment from R. communis (PCT WO 94/11516); Bnfad2, fad2 desaturase from Brassica napus (PCT WO 94/11516); LFFAH12.AMI, SEQ ID NO: 4; FAH12.AMI, SEQ ID NO: 5; ATFAD2.AMI, SEQ ID NO: 6; BNFAD2.AMI, SEQ ID NO: 7; GMFAD2-1.AMI, SEQ ID NO: 8; GMFAD2-2. AMI, SEQ ID NO: 9; ZMFAD2.AMI, SEQ ID NO: 10; and RCFAD2.AMI, SEQ ID NO: 11.
Figure 10 shows a Southern blot of genomic DNA from L. fendleri probed with pLesq-HYD. E = EcoRI, H = HindIII, X = Xbal.
Figure 11 shows a map of the binary Ti plasmid PSLJ44024.
Figure 12 shows a map of the plasmid pYES2.0
Figure 13 shows part of a gas chromatogram of the fatty acids derivatized from yeast cells containing the plasmid pLesqYes in which the expression of the idroxylase gene was induced by the addition of galactose to the growth medium. The arrow points to a peak that is not present in the non-induced cells. The lower part of the figure is the mass spectrum of the peak indicated by the arrow.
BRIEF DESCRIPTION OF THE INVENTION
This invention relates to acyl-fatty-hydroxylases of plants. Methods for using conserved amino acid or nucleotide sequences to obtain acyl-fatty-hydroxylases from plants are described. The use of cDNA clones encoding a plant hydroxylase to produce a family of hydroxylated fatty acids in transgenic plants is also described.
In a first embodiment, this invention is directed to recombinant DNA constructs that can provide transcription, or transcription and translation (expression) of the kappa-hydroxylase sequence of the plant. In particular, constructs that are capable of transcription, or of transcription and translation in host cells of the plant are preferred. These constructs may contain a variety of regulatory genes that include transcriptional initiation regions obtained from genes preferentially expressed in the tissue of the plant seeds. In a second aspect, this invention relates to the presence of these constructs in host cells, especially plant host cells having a plant kappa-hydroxylase, expressed, therein. In yet another aspect, this invention relates to a method for producing a plant kappa-hydroxylase in a host cell or progeny thereof via the expression of a cell construct. Cells containing a plant kappa-hydroxylase as a result of production of the sequence coding for plant kappa-hydroxylase are also contemplated herein.
In another embodiment, this invention relates to methods for using a DNA sequence encoding a plant kappa-hydroxylase for modifying the proportion of the hydroxylated fatty acids produced within a cell, especially plant cell. Plant cells having this modified hydroxylated fatty acid composition are also contemplated herein. In a further aspect of this invention, plant kappa-hydroxylase proteins, and sequences that are related thereto, including the amino acid and nucleic acid sequences, are contemplated. The plant kappa-hydroxylase exemplified herein includes the fatty acid-hydroxylase of Lesquerella fendleri. This exemplified fatty acid hydroxylase can be used to obtain other plant fatty acid-hydroxylases of this invention. In a further aspect of this invention, a nucleic acid sequence that directs seed-specific expression of an associated polypeptide coding sequence is described. The use of this nucleic acid sequence or derivatives thereof to obtain seed-specific expression in higher plants of any coding sequence is contemplated herein. In a further aspect of this invention, the use of genes encoding the acyl-fatty hydroxylases of this invention is used to alter the amount of fatty acid unsaturation of the lipids of the seed. The present invention further describes the use of genes of hydroxylase and desaturases, genetically modified, to achieve the targeted modification of the levels of unsaturation of fatty acids.
DETAILED DESCRIPTION OF THE INVENTION
A genetically transformed plant of the present invention that accumulates hydroxylated fatty acids can be obtained by expressing the double-stranded DNA molecules described in this application. A plant-fatty acid hydroxylase of this invention includes any amino acid sequence, such as a protein, polypeptide or peptide fragment, or nucleic acid sequences encoding these polypeptides, obtainable from a plant source demonstrating the ability to catalyze the production of ricinoleic, lesqueroic, hydroxy-erucic (16-hydroxidoc-cis-13-enoic acid) or hydroxy-limetoleic acid (12-hydroxyhexadec-cis-9-enoic acid) from the linked monoenoic fatty acid substrates to CoA, ACP or lipids, under reactive conditions of plant enzymes. By "reactive enzyme conditions" it is meant that any of the necessary conditions are available in an environment (i.e., factors such as temperature, pH, lack of inhibitory substances) that will allow the enzyme to function. The preferential activity of a plant fatty acid-hydroxylase towards a particular fatty acid substrate is determined in comparison to the amounts of the hydroxylated fatty acid product obtained by different fatty acyl substrates. For example, by "which prefers oleate" is meant that the hydroxylase activity of the enzyme preparation demonstrates a preference for substrates containing oleates on other substrates. Although the precise substrate of castor-acid-hydroxylase of castor is not known, it is thought that it is a portion of unsaturated fatty acid that is esterified to a phospholipid such as phosphatidylcholine.
However, it is also possible that the mono-unsaturated fatty acids esterified to phosphatidylethanolamine, phosphatidic acid or a neutral lipid such as diacylglycerol or the thioester of co-enzyme-A can also be substrates. As noted above, significant activity has been observed in radioactive labeling studies using fatty acyl substrates other than oleate (Ho ling et al., 1972) indicating that the specificity of the substrate is for a family of related fatty acyl compounds. Because castor hydroxylase introduces three carbon hydroxy groups from a double bond, close to the methyl-carbon of the fatty acid, the enzyme is called a kappa-hydroxylase for convenience. Of particular interest, the present invention discloses that castor kappa-hydroxylase can be used for the production of 12-hydroxy-9-octadecenoic acid (ricinooleate), 12-hydroxy-9-hexadecenoic acid, 14-hydroxy-11- acid eicosenoic, 16-hydroxy-16-docosenoic acid, 9-hydroxy-6-octadecenoic acid by expression in plant species that produce non-hydroxylated precursors. The present invention also describes the production of additionally modified fatty acids such as 12-hydroxy-9, 15-octadecadienoic acid resulting from the desaturation of hydroxylated fatty acids (eg, 12-hydroxy-9-octadecenoic acid in this example). ). The present invention also discloses that future developments in the genetic engineering of plants will lead to the production of substrate fatty acids, such as icosoic acid esters, and palmitoleic acid esters in plants that do not normally accumulate these fatty acids. The invention described herein can be used in conjunction with these future improvements to produce hydroxylated fatty acids of this invention in any of the plant species that respond to direct genetic modification. In this way, the applicability of this invention is not limited to the present conception only of those species that currently accumulate suitable substrates. As noted above, a plant kappa-hydroxylase of this invention will exhibit activity towards various fatty acyl substrates. During the biosynthesis of the lipids in a plant cell, the fatty acids are typically covalently bound to the acyl carrier protein (ACP), co-enzyme-A (CoA) or various cellular lipids.
Plant kappa-hydroxylase which exhibit preferential activity towards the lipid-bound acyl substrate are especially preferred because they are probably more closely associated with the normal route of lipid synthesis or storage in immature embryos. However, activity towards acyl-CoA substrates or other synthetic substrates is also contemplated herein, by way of example. Other plant kappa-hydroxylases can be obtained from the exemplified, specific sequences provided herein. Additionally, it will be apparent that natural and synthetic plant kappa-hydroxylase can be obtained, including the modified amino acid sequences and starting materials for the modeling of synthetic proteins for the plant kappa-hydroxylase exemplified and from the plant kappa-hydroxylases. which are obtained from the use of these exemplified sequences. Modified amino acid sequences include sequences that have not been mutated, truncated, elongated or the like, if these sequences were partially or completely synthesized. The sequences that are actually purified from plant preparations or are identical or code for proteins identical thereto, without considering the method used to obtain the protein or sequence, are also considered naturally derived. In this manner, one skilled in the art will readily recognize that antibody preparations, nucleic acid probes (DNA and RNA) or the like can be prepared and used to detect and recover "homologous" or "related" kappa-hydroxylases from a variety of plant sources. Typically, the nucleic acid probes are killed to allow detection, preferably with radioactivity although enzymes or other methods can be used. For immunological detection methods, antibody preparations either monoclonal or polyclonal are used. Polyclonal antibodies, although less specific, are typically more useful in gene isolation. For detection, the antibody is labeled using radioactivity or any of a variety of second antibody / enzyme conjugate systems that are commercially available. Homologous sequences are found when there is a sequence entity and can be determined in the comparison of the sequence information, nucleic acid or amino acid, or through the hybridization reactions between a known kappa-hydroxylase and a candidate source. Conservative changes, such as Val / lie, Ser / Thr, Arg / Lys and Gln / Asn can also be considered in determining the homology of the sequence. Typically, a long nucleic acid sequence can show as little as 50-60% sequence identity, more preferably at least 70% sequence entity, between the target sequence and the given plant kappa-hydroxylase of interest excluding any of the deletions that may be presented, and is still considered related. The amino acid sequences are considered homologous for as little as 25% sequence entity between the two complete mature proteins (see generally Doolittle, R.F., OF URFS and ORFS, University Science Books, CA, 1986). A suitable genomic or other library prepared from the candidate plant source of interest can be probed with the conserved sequences from the plant kappa-hydroxylase to identify the homologously related sequences. The use of a complete cDNA or other sequence can be used if the shorter probe sequences are not identified. The positive clones are then analyzed by digestion with restriction enzymes and / or sequencing. When a genomic library is used, one or more sequences can be identified by providing both the modification region, as well as the transcriptional regulatory elements of the kappa-hydroxylase gene from this plant source. Also the probes can be considerably shorter than the complete sequence. Oligonucleotides, for example, may be used, but must be at least about 10, preferably at least about 15, more preferably at least 20 nucleotides in length. When regions with shorter length are used for comparison, a greater degree of sequence entity is required for the longer sequences. Frequently, shorter probes are particularly useful for polymerase chain reactions (PCR), especially when highly conserved sequences can be identified (see Gould et al. 1989 for examples of the use of PCRs to isolate homologous genes from taxonomic species. diverse). When longer nucleic acid fragments are used (>; 100 bp) as probes, especially when full or long cDNA sequences are used, is detected with little severity (for example, 40-50 ° C below the melting temperature of the probes) in order to obtain the signal to from the target sample with 20-50% deviation, that is, homologous sequences (Beltz et al., 1983). In a preferred embodiment, a plant kappa-hydroxylase of this invention will have at least 60% similarity of the complete amino acid sequence to the plant kappa-hydroxylase, exemplified. In particular, the kappa-hydroxylases that can be obtained from an amino acid sequence or nucleic acid of a kappa-hydroxylase from castor or Lesquerella are especially preferred. The plant kappa-hydroxylase may have preferential activity towards the longer or shorter chain fatty acyl extracts. Plant acyl-fatty hydroxylases having oleate-12-hydroxylase activity and eicosenoate-14-hydroxylase activity are considered both homologously related proteins due to in vitro evidence (Howling et al., 1972), and the evidence described in The present, castor kappa-hydroxylase will act on both substrates. Hydroxylated fatty acids can be subjected to further enzymatic modification with other enzymes that are normally present, or introduced by genetic engineering methods. For example, 14-hydroxy-11,17-eicosadienoic acid, which is present in some Lesquerella species (Smith, 1985), is thought to be produced by the desaturation of 14-hydroxy-11-eicosenoic acid. Again, not only clones and materials derived therefrom can be used to identify plant acyl-fatty-hydroxylases, homologues, but the resulting sequences obtained therefrom can also provide an additional method to obtain the acyl-fatty-hydroxylases. of plant from other plant sources. In particular, PCR can be a useful technique for obtaining the related acyl-plant-hydroxylases from the plant, from the sequence data provided herein. A person skilled in the art will be able to designate oligonucleotide probes based on comparisons of the highly conserved sequence typically. Of special interest are the primers of the polymerase chain reaction based on the conserved regions of the amino acid sequences between the kappa-hydroxylase of castor and the hydroxylase of L. fendleri (SEQ ID NO: 4). The details relate to the design and methods for a PCR reaction using these probes are described more fully in the examples. It should also be noted that acyl hydroxylases from a variety of sources can be used to investigate cases of fatty acid hydroxylation in a wide variety of plant applications and in vivo. Because all plants synthesize fatty acids via a common metabolic pathway, the study and / or application of a plant fatty acid-hydroxylase to a heterologous plant host can be easily achieved in a variety of species. Once the nucleic acid sequence is obtained, the transcription, or transcription and translation (expression), of the plant acyl hydroxylases in a host cell is desired to produce a ready source of the enzyme and / or to modify the composition of the fatty acids found therein in the form of free fatty acids, esters (particularly esterified to glycerolipids or as components of wax esters), stolides, or ethers. Other useful applications can be found when the host cell is a plant host cell, in vitro and in vivo. For example, by increasing the amount of a kappa-hydroxylase available in the plant, an increased percentage of ricinoleate or leseroleate (14-hydroxy-11-eicosenoic acid) 'can be provided.
Kappa-hydroxylase
For this invention, a mechanism for the biosynthesis of ricyloleic acid in plants is demonstrated. Specifically, that a specific plant kappa-hydroxylase having preferential activity towards fatty acyl substrates is comprised in the accumulation of hydroxylated fatty acids in at least some plant species. The use of the terms ricinoleate or ricinoleic acid (or lesqueroleate or lesquerólico acid, densipoleato, etc.) is proposed to include the free acids, esters of ACP and CoA, the salts of these acids, esters of glycerolipids (particularly esters of triacylglycerol), the esters of waxes, the stolides and the ether derivatives of these acids. The determination that plant acyl-fatty-hydroxylases are active in the in vivo production of hydroxylated fatty acids suggest several possibilities for plant enzyme sources.
Actually, hydroxylated fatty acids are found in the same species of natural plants in abundance. For example, three hydroxy fatty acids related to ricinoleate are present in higher amounts in seed oils from several Lesquerella species. Of particular interest, lesqueroic acid is a homolog of 20 carbon atoms of ricinoleate with two additional carbon atoms at the carboxyl end of the chain (Smith, 1985). Other natural plant sources of the hydroxylated fatty acids include, but are not limited to, seeds of the Linum genus, seeds of the Wrigthtia species, Lycopodium species, Strophanthus species, Convolvulaces species, Calendula species and many others (van de Loo et al., 1993). Plants that have a significant presence of ricinoleate or leskoleate or other desaturated or modified derivatives of these fatty acids are preferred candidates for naturally obtaining kappa-hydroxylases. For example, Lesquerella densipila contains a fatty acid of 18 carbon atoms, diunsaturated with a hydroxyl group (van de Loo et al., 1993) that is thought to be produced by an enzyme that is closely related to castor kappa-hydroxylase. , according to the theory on which this invention is based. In addition, a comparison between the kappa-hydroxylases and between the plant acyl-fatty-hydroxylases that introduce hydroxyl groups at different positions of the 12-carbon oleate atom or 14 carbon-atom of lescaroleate or into different substrates of the nucleic acid and Icosenoic acid can produce insights for gene identification, protein modeling or other modifications as discussed above. Especially of interest are the acyl-fatty hydroxylases which demonstrate activity towards the fatty acyl substrates other than oleate or which introduce the hydroxyl group to a different location of the carbon atom 12. As described above, other plant sources can also provide Sources of these enzymes through the use of protein purification, nucleic acid probes, antibody preparations, protein modeling, or sequence comparisons, for example, and of particular interest are the respective amino acid and nucleic acid sequences, which correspond to these plant acyl-fatty-hydroxylases. Also, as described previously, once a given nucleic acid sequence for the plant hydroxylase is obtained, the additional plant sequences can be compared and / or probed to obtain the DNA sequences homologously related thereto and thus successively.
Genetic Engineering Applications
As is well known in the art, once the cDNA clone encoding a plant kappa-hydroxylase is obtained, it can be used to obtain its corresponding, corresponding, genomic nucleic acid sequences thereto. Nucleic acid sequences encoding plant kappa-hydroxylases can be used in various constructions, for example, as probes to obtain additional sequences from the same or other species. Alternatively, these sequences can be used in conjunction with appropriate regulatory sequences to increase the levels of the respective hydroxylase of interest in a host cell for the production of hydroxylated fatty acids or the study of the enzyme in vitro or in vivo or to decrease or increasing the levels of the respective hydroxylase of interest for the same applications when the host cell is a plant entity, including plant cells, plant parts (including but not limited to seeds, species or tissues) and plants. The nucleic acid sequence encoding a plant kappa-hydroxylase of this invention may include the genomic sequence, cDNA or mRNA. By "coding" it is meant that the sequence corresponds to a particular amino acid sequence either in a homosense or antisense orientation. By "recombinant" is meant that the sequence contains a genetically engineered modification through manipulation via mutagenesis, restriction enzymes, or the like. A cDNA sequence can encode pre-processing sequences, or not, such as transit or signal peptide sequences. The peptide or transit or signal sequences facilitate the distribution of the protein to a given organelle and are frequently cleaved from the polypeptide at the entrance to the organelle, releasing the "mature" sequence. The use of the precursor DNA sequence is preferred in the plant cell expression cartridges. Additionally, as discussed above, the complete genomic sequence of plant kappa-hydroxylase can be obtained by detecting a genomic library with a probe, such as a cDNA probe, and isolating those sequences that regulate expression in the plant tissue. Once the desired nucleic acid sequence of the plant kappa-hydroxylase is obtained, it can be manipulated in a variety of ways. Where the sequence comprises flanking regions of non-coding, the flanking regions can be subjected to reception, mutagenesis, etc. In this way, transitions, transversions, deletions, insertions can be made in the sequence that occurs naturally. In addition, all or part of the sequence can be synthesized. In the structural gene, one or more codons may be modified to provide a modified amino acid sequence, or one or more codon mutations may be introduced to provide a convenient restriction site or other purpose comprised with the construct or expression. The structural gene can be further modified by employing synthetic adapters, linkers to introduce one or more convenient restriction sites, or the like.
The nucleic acid or amino acid sequences encoding a plant kappa-hydroxylase of this invention can be combined with other non-native, or "heterologous" sequences in a variety of ways. By "heterologous" sequences is meant any sequence that is not naturally bound to the plant kappa-hydroxylase, which includes, for example, the combination of nucleic acid sequences from the same plant that are not found naturally united together. The DNA sequence encoding a plant kappa-hydroxylase of this invention can be used in conjunction with all or part of the gene sequences normally associated with kappa-hydroxylase. In its component parts, a DNA sequence coding for a kappa-hydroxylase is combined in a DNA construct having, in the 5 'to 3' direction of the transcription, a transcription initiation control region capable of promoting transcription and / or translation in a host cell, the DNA sequence encoding the plant kappa-hydroxylase and a transcription and / or translation termination region.
Potential host cells include both prokaryotic and eukaryotic cells. A host cell can be unicellular or is found in a multicellular, differentiated or undifferentiated organism, depending on the proposed use. The cells of this invention can be distinguished by having a plant kappa-hydroxylase foreign to the wild type cell present therein, for example, by having a recombinant nucleic acid construct encoding a plant kappa-hydroxylase therein. . Depending on the host, the regulatory regions will vary, including regions of viral, plasmid or chromosomal genes, or the like. By the expression in prokaryotic or eukaryotic microorganisms, particularly in unicellular hosts, a wide variety of constitutive or regulatable promoters can be employed. Expression in a microorganism can provide a ready source of the plant enzyme. Among the transcriptional initiation regions that have been described are the regions of the bacterial and yeast hosts, such as E. coli, B. subtilis, saccharomyces cerevisiae, including genes such as beta-galactosidase, T7-polymerase, trpE and the like .
For the most part, the constructions will comprise functional regulatory regions of plants that provide modified production of the plant kappa-hydroxylase with the resulting modification of the composition of the fatty acids. The open reading frame, which codes for the plant kappa-hydroxylase or the functional fragment thereof will be bound at its 5 'end to a regulatory region of transcription initiation. Numerous regions of transcription initiation are available that provide a wide variety of constitutive or regulatable, eg, inducible, transcription of structural gene functions. Among the transcriptional initiation regions used for plants are regions associated with structural genes such as nopaline monopin-synthases, or with napin-soybean-β-conglycinin, oleosin, storage protein 12S, promoters of the 35S mosaic virus of cauliflower, or similar. The transcription / translation initiation regions corresponding to these structural genes are located immediately in the 5 'direction at the respective start codons. In embodiments, wherein the expression of the kappa-hydroxylase protein is desired in a plant host, the use of all or part of the complete plant kappa-hydroxylase gene is desired. If a different promoter is desired, such as a promoter inactive to the plant host of interest or a modified promoter, ie, having transcription initiation regions derived from a gene source and translation initiation regions derived from a different gene source or improved promoters, such as double 35S-CaMV promoters, the sequences can be joined together using normal techniques. For these applications, when the 5 'non-coding regions are obtained from other genes regulated during seed maturation, those preferentially expressed in the tissue of the embryos of the plant, such as the initiation control regions, are desired. of transcription from the napina gene of B. napus, or the 12S storage protein of Arabidopsis, or soybean-β-conclicinin (Bray et al., 1987). Transcription initiation regions that are preferentially expressed in the seed tissue, ie, that are detectable in other plant parts, are considered desirable for fatty acid modifications in order to minimize any of the reducing or adverse effects. of the gene product. The termination regions of the regulatory transcript can also be provided in the DNA constructs of this invention. The transcript termination regions can be provided by the DNA sequence encoding the plant kappa-hydroxylase or a convenient transcription termination region derived from a different gene source, for example, the transcript termination region that it is associated in a natural way with the region of initiation of the transcript. When the region of transcript termination is from a different gene source, it will contain at least about 0.5 kb, preferably about 1-3 kb of the 3 'sequence to the structural gene from which the terminating region is derived. Expression or transcription constructs of the plant having a plant kappa-hydroxylase as the DNA sequence of interest for increased or decreased expression thereof may be employed with a wide variety of plant life, particularly, life span. plant included in the production of vegetable oils for edible or industrial uses. The most especially preferred crops are the oil seed cultures, tempered. The plants of interest include, but are not limited to anything (cañola and varieties of high erucic content), Crambe, Brassica júncea, Brassica nigra, carricera, linseed, sunflower, safflower, cotton, Cuphea, soybean, peanut, coconut palms and oil and corn. An important criterion in the selection of suitable plants for introduction into kappa-hydroxylase is the presence in the host plant of a substrate suitable for hydroxylase. Thus, for example, the production of ricinoleic acid will be best achieved in plants that normally have high levels of ricinoleic acid in the lipids of the seed. Similarly, the production of lesqueroic acid will be best achieved in plants that have high levels of icosoic acid in the lipids of the seeds. Depending on the method for introducing the recombinant constructs into the host cells, other DNA sequences may be required. Importantly, this invention can be applied to different dicotyledonous and monocotyledonous species and will be readily applicable to new and / or improved transformation and regulation techniques. The transformation method is not critical to the present invention; Various methods of plant transformation are currently available. Since newer methods are available to transform crops, they can be applied directly later. For example, many plant species naturally susceptible to the infection of agrobacterium can be successfully transformed via tripartite or binary vector methods of transformation mediated by agrobacterium. In addition, microinjection techniques have been developed, bombardment of DNA particles, electroporation, which allows the transportation of several species of monocotyledonous and dicotyledonous plants. In the development of DNA construction, the various components of the construct or fragments thereof will normally be inserted into a convenient cloning vector that is capable of replication in a bacterial host, e.g., E. coli. Numerous vectors have been described in the literature. After each cloning, the plasmid can be isolated and subjected to further manipulation, such as restriction, insertion of new fragments, ligation, suppression, insertion, resection, etc., to provide the components of the desired sequence. Once the construction has been completed, it can then be transferred to an appropriate vector for further manipulation according to the manner of transformation of the host cell. Normally, included with the construction of
DNA will be a structural gene that has the regulatory regions necessary for expression in a host and that provides for the selection of transformed cells. The example of providing resistance to a cytotoxic agent, for example, antibiotic, heavy metal, toxin, etc., prototropia that provides complementation, for an auxotrophic host, viral immunity or the like. Depending on the number of different host species, the expression construct or the components therein are introduced, one or more markers may be used, where different conditions are used for selection for the different hosts. It is pointed out that the regeneration of the DNA code provides that some codon substitutions are permissible for the DNA sequences without any corresponding modification of the amino acid sequence. As mentioned above, the manner in which the DNA construct is introduced into the plant host is not critical to this invention.
Any method that provides efficient transformation can be employed. Various methods for the transformation of plant cells include the use of Ti- or Ri- plasmids, microinjection, electroporation, infiltration, inhibition, bombardment of DNA particles, fusion of liposomes, bombardment of DNA or the like. In many cases, it will be desirable to have the construction limited on one or both sides of the T-DNA, which has particularly the left and right boundaries, more particularly the right boundary. This is particularly useful when the construction uses A. tumefaciens or A. rhizogenes as a mode for transformation, although the T-DNA boundaries may find use with other modes of transformation. When Agrobacterium is used for the transformation of plant cells, a vector that can be introduced into the host of Agrobacterium for homologous recombination with T-DNA or the Ti- or Riplasmid present in the host of Agrobacterium can be used. The Ti or Ri-plasmid containing the T-DNA for recombination can be armed (capable of causing the formation of bile) or disarmed (unable to cause bile), the latter being permissible, while the vir genes are present in the host of Agrobacterium, transformed. The armed plasmid can give a mixture of normal plant cells and bile. In some cases where Agrobacterium is used as the vehicle to transform the plant cells, the expression construct limited by the T-DNA boundaries will be inserted into a broad-spectrum host vector, which are broad-spectrum host vectors described in Literature. Commonly used is pRK2 or derivatives thereof. See, for example, Ditta et al. (1980), which is incorporated herein by reference. Included with the expression construct and the T-DNA will be one or more markers, which allow the selection of the transformed Agrobacterium and the transformed plant cells. A number of markers have been developed for use with plant cells, such as resistance in kanamycin, aminoglycoside G418, hygromycin, or the like. The particular marker employed is not essential to this invention, one or the other marker being preferred depending on the particular host and the manner of construction. For the transformation of plant cells using Agrobacterium, the explants can be combined and incubated with the transformed Agrobacterium for a sufficient time for transformation, dead bacteria, and plant cells grown in a selective, appropriate medium. Once the calluses are formed, shoot formation can be stimulated by using the appropriate plant hormones according to known methods and the shoots are transferred to the implanting medium for regeneration of the plants. Then, the plants can be grown to seeds and the seeds are used to establish repetitive generations and for the isolation of vegetable oils.
Use of Hydroxylase Genes to Alter Acid-Fatty Desaturases Activity
A widely known goal of common efforts to improve the nutritional quality of edible plant oils, or to facilitate industrial applications of plant oils, is to alter the level of unsaturation of plant storage lipids (Topfer and collaborators, 1995). In particular, in many crop species, it is desired to substantially reduce the level of polyunsaturation of the storage lipids and increase the level of the oleic acid. The precise amount of the various fatty acids in a particular plant oil varies with the proposed application. In this way, it is desirable to have a strong method that will allow genetic manipulation of the level of unsaturation at any desired level. A substantial progress has been made recently in the isolation of genes coding for plant fatty acid desaturases (reviewed in Topfer et al., 1995). These genes have been introduced into several plant species and have been used to alter the level of unsaturation of fatty acids in one of three ways. First, the genes can be placed under the transcriptional control of a strong promoter so that the amount of the corresponding enzyme is increased. In some cases, this leads to an increase in the amount of the fatty acid which is a product of the reaction catalyzed by the enzyme. For example, Arondel et al. (1992) increased the amount of linoleic acid (18: 3) in tissues of transgenic Arabidopsis plants by placing the fad3 gene located in the endoplasmic reticulum, under the transcriptional control of the 35S virus promoter of the mosaic. the cauliflower, constitutive, strong.
A second method for using the cloned genes to alter the level of unsaturation in the fatty acids is to cause the transcription of all or part of a gene in transgenic tissues, so that the transcripts have an antisense orientation relative to the normal mode of transcription. This has been used by a number of laboratories to reduce the level of expression of one or more desaturase genes having a significant homology of the nucleotide sequence to the gene used in the construction of the antisense gene (reviewed in Topfer et al.). For example, the antisense repression of desaturase oleate-12 in transgenic naba resulted in a strong increase in oleic acid content (compare, Topfer et al., 1995). A third method for using cloned genes to alter fatty acid desaturation is to exploit the phenomenon of co-suppression or "gene slowing" (Matzke et al., 1995). Although the mechanisms responsible for gene lentification are not known in any detail, it has been frequently observed that in transgenic plants the expression of an introduced gene leads to the inactivation of homologous endogenous genes.
For example, the high-level homosense expression of the fad8 gene of Arabidopsis, which codes for a? 15 of saturase localized in the chloroplast, in transgenic plants of Arabidopsis caused suppression of the endogenous copy of the fad8 gene and the homologous fad7 gene (coding an isozyme of the fadd gene) (Gibson et al., 1994). The fad7 and fadd genes are only 76% identical at the nucleotide level. At the time of publication, this example represented the most divergent pair of plant genes for which co-suppression has been observed. In view of the prior evidence that relates to the relatively high level of nucleotide sequence homology required to obtain co-suppression, it is not obvious to one skilled in the art that homosense expression in acyl-fatty transgenic plants Castor-hydroxylase of this invention would significantly alter the saturation amount of the storage lipids. However, the present inventors state that the acyl-fatty hydroxylase genes can be used for this purpose as taught in Example 4 of this specification. Of particular importance, this invention teaches the use of the acyl-fatty-hydroxylase genes to increase the proportion of oleic acid in tissues of transgenic plants. The mechanism by which the expression of the gene exerts this effect is not known, but may be due to one of several possibilities that are elaborated in Example 4. The invention that has now been described in general, will be more easily understood by reference to the following examples which are included for purposes of illustration only and are not intended to limit the present invention.
EXAMPLES
In the experimental description that follows, all temperatures are given in degrees centigrade
(° C), the weights are given in grams (g), milligrams (mg) or micrograms (μg), the concentrations are given as molar (M), millimolar (mM) or micromolar (μM) and all volumes are given in liters (1), microliters (μl) or milliliters (ml), unless otherwise indicated.
EXAMPLE 1 - PRODUCTION OF NEW HYDROXYLED FATTY ACIDS IN ARABIDOPSIS THALIANA
Global appraisal
The kappa-hydroxylase encoded by the fahl2 gene of castor bean was used to produce ricinoleic acid, lesqueroic acid, densipholic acid and auricolic acid in transgenic Arabidopsis plants.
Production of transgenic plants
A variety of methods have been developed to insert a DNA sequence of interest into the genome of a plant host to obtain the transcription and translation of the sequence to effect the phenotypic changes. The following methods represent only one of many equivalent means for producing transgenic plants and causing expression of the hydroxylase gene. Arabidopsis plants were transformed, by the Agrobacterium-mediated transformation, with the kappa-hydroxylase encoded by the fahl2 gene of castor into the binary pB6 Ti-plasmid. This plasmid has also been used to transform Nicotiana tabacum for the production of ricinoleic acid. The inocula of the Agrobacterium tumefaciens strain GV3101 containing the binary plasmid pB6 were placed in L-broth plates containing 50 μg / ml kanamycin and incubated for 2 days at 30 ° C. Individual colonies were used to inoculate large liquid cultures (medium of L-broth with 50 mg / l of rifampin, 110 mg / l of gentamicin and 200 mg / l of kanamycin) to be used for the transformation of Arabidopsis plants . The Arabidopsis plants were transformed by the plant transformation process essentially as described by Bechtold et al. (1993). The cells of A. tumefaciens GV3101 (pB6) were harvested from the liquid cultures by centrifugation, then redispersed in the infiltration medium at OD6oo = 0.8. The filtration medium was Murashige and Skoog macro and the micronutrient medium (Sigma Chemical Co., St. Louis, MO) containing 10 mg / l of 6-benzylaminopurine and 5% glucose. The batches of 12-15 plants were grown during 3 to 4 weeks in natural light at an average daily temperature of approximately 25 ° C in 3.5-inch pots containing soil. The intact plants were immersed in the bacterial suspension, then transferred to a vacuum chamber and placed under 600 nm of vacuum produced by a laboratory vacuum pump until the tissues appeared to be uniformly soaked with water (approximately 10 minutes). The plants were grown at 25 ° C under continuous light (100 μmol m 's' 1 irradiation in the range of 400 to 700 not shown) for four weeks. The seeds obtained from all the plants in a pot were collected as a batch. Seeds were sterilized by sequential treatment for 2 minutes with ethanol followed by 10 minutes in a mixture of household bleach (Clorox), water and Tween 80 (50%, 50%, 0.05%) then thoroughly rinsed with sterile water. The seeds were plated at high density (2000 to 4000 per plate) in the medium solidified with agar in 100 mm petri dishes containing the medium of the Murashige and Skoog 1/2 X salts enriched with vitamins B5 (Sigma Chemical Co., St. Louis, MO) and containing kanamycin at 50 mg / l. After incubation for 48 h at 4 ° C to stimulate germination, the saplings were grown for a period of seven days until the transformants were clearly identifiable as healthy green trees against a backdrop of sapwood trees sensitive to kanamycin, chlorotic. The transformants were transferred to a solid for two weeks before the tissue of the sheet could be used for DNA and lipid analysis. More than 20 transformants were obtained. The DNA was extracted from the young leaves of the transformants to verify the presence of an intact fahl2 gene. The presence of the transgene in a number of putative transgenic lines was verified by using the polymerase chain reaction to amplify the pB6 insert. The primers used were HF2 = GCTCTTTTGTGCGCTCATTC
(SEQ ID NO: 12) and HR1 = CGGTACCAGAAAACGCCTTG (SEQ ID NO: 13), which were designed to allow the amplification of 700 bp fragments. Approximately 100 mg of genomic DNA was added to a solution containing 25 pmol of each primer, 1.5 U of Taq polymerase (Boeringer Manheim), 200 uM of dNTPs, 50 mM KCl, 10 M Tris.Cl, (pH 9), 0.1 % (w / w) of Triton X-100, 1.5 mM MgCl2, 3% formamide (w / w), to a final volume of 50 μl. The amplification conditions were: denaturation step of 4 minutes at 94 ° C, followed by 30 cycles of 92 ° C for 1 minute, 55 ° C for 1 minute, 72 ° C for 2 minutes. A final extension step closed the program at 72 ° C for 2 minutes. Transformants were positively identified after visualization of a characteristic 1 kb amplified fragment on an agarose gel stained with ethidium bromide. All the transgenic characteristics tested yielded a PCR product of a size consistent with the expected genotype, confirming that the lines were, in fact, transgenic. All additional experiments were done with three transgenic lines representative of the wild type designated 1-3, 4D, 7-4 and a transgenic line of the mutant line JB12 of fad2. The transgenic line of JB12 was included in order to test whether the increased accumulation of oleic acid in this mutant would have an effect on the amount of ricinoleic acid that accumulates in the transgenic plants.
Analysis of Transgenic Plants
The leaves and seeds from the transgenic Arabidopsis plants of fahl2 were analyzed for the presence of hydroxylated fatty acids using gas chromatography. The lipids were extracted from 100-200 mg leaf tissue or 50 seeds. Fatty acid methyl esters (FAMES) were prepared by placing the tissue in 1.5 ml of 1.0 M methanolic HCl (Supelco Co.) in a 13 x 10 mm screw cap glass tube capped with a teflon-lined cap and heated at 80 ° C for 2 hours. On cooling, 1 ml of petroleum ether was added and the FAMES was removed by completely aspirating the ether phase which was then dried under a stream of hydrogen in a glass tube. One hundred μl of N, O-bis (trimethylsilyl) -trifluoroacetamide (BSTFA, Pierce Chemical Co.) and 200 μl of acetonitrile were designated to derivatize the hydroxyl groups. The reaction was carried out at 70 ° C for 15 minutes. The products were dried under nitrogen, redissolved in 100 μl of chloroform and transferred to a gas chromatography bottle. Two μl of each sample was analyzed on a fused silica capillary column, SP2340 (30 m, ID 0.75 mm, 0.20 mm film, Supelco), using a Gas Chromatograph Series 5890-11, Hewlett-Packard. The samples were not divided, the temperature program was 195 ° C for 18 minutes, it was increased to 230 ° C at 25 ° C / minute, it was maintained at 230 ° C for 5 minutes then it was lowered to 195 ° C at 25 ° C / minute, and flame ionization detectors were used.
The chromatographic elution time of the methyl esters and the O-TMS derivatives of ricinoleic acid, lesqueroic acid and auricolic acid were established by GC-MS of the lipid samples from L fendleri seeds and compared to the chromatograms published on the fatty acids of these species (Carlson et al., 1990). A standard of O-TMS-methyl-ricinoleate was prepared from the ricinoleic acid obtained from Sigma Chemical Co. (St., Luis, MO). Standards of O-TMS-methyl-lesqueroleate and O-TMS-methyl-auricoleate were prepared from purified triacylglycerols from L. fendleri seeds. The mass spectrum of O-TMS-methyl-ricinoleate, O-TMS-methyl-densipolyate, 0-TMS-methyl-leskoleate, and O-TMS-methyl-auricoleate are shown in Figures 1A-D, respectively. The structures of the characteristic ions produced during the mass spectrometry of their derivatives are shown in Figure 2. The lipid extracted from the transgenic tissues was analyzed by gas chromatography and mass spectrometry for hydroxylated fatty acid spectrometry. As a reference material, the average fatty acid composition of the leaves in wild type Arabidopsis and the fad2 mutant lines are reported by Miguel and Browse (1992). The gas chromatograms of the methylated and silylated fatty acids of these wild-type seeds and a fahl2 transgenic wild-type plant are shown in Figures 3A and 3B, respectively. The profiles are very similar except for the presence of three small peaks, very different, at 14.3, 15.9 and 18.9 minutes. A very small peak at 20.15 minutes was also evident. The elution time of the peaks at 14.3 and 18.9 minutes corresponded precisely to that of the standards of ricinoleic and lesqueroic acid, comparably prepared, respectively. No significant differences were observed in the lipid extracts of the leaves or roots of the wild type and the transgenic wild type lines fahl2 (Table 1). Thus, despite the fact that the fahl2 gene is expressed throughout the plant, the effects on fatty acid composition were observed only in the seed tissue. A similar observation has been made for transgenic fahl2 tobacco.
Table 1. Fatty acid composition of lipids from the wild-type transgenic type of Arabidopsis. The values are the average obtained from the analysis of the samples from three independent transgenic lines,. or three independent samples of the wild type and fad2 lines.
Table 1
Table 1 (continued)
In order to confirm that the new peaks observed, the transgenic lines correspond to ricinoleic, lesqueroic, densipolic and auricolic acid derivatives, mass spectrometry was used. The fatty acid derivatives were determined by gas chromatography as described above except that a mass selective detector of the Hewlett-Packard series 5971 was used in place of the flame ionization detector used in the previous experiment. The spectrum of the four new peaks in Figure 3B (peak numbers 10, 11, 12, and 13) are shown in Figures 4A-D, respectively. The comparison of the spectrum obtained for the standards with that obtained for the 4 peaks from the transgenic lines confirms the identity of the four new peaks. Based on the three characteristic peaks at M / Z 187, 270 and 299, peak 10 is unambiguously identified as O-TMS-methylricinoleate. Based on the three characteristic peaks at M / Z 185, 270 and 299, peak 11 is unambiguously identified as O-TMS-methyldensipoleate. Based on the three characteristic peaks at M / Z 187, 298 and 327, peak 12 is unambiguously identified as O-TMS-methyl-geraseleate. Based on the three characteristic peaks at M / Z 185, 298 and 327, peak 13 is inambiguously identified as O-TMS-methylauricoleate. These results unequivocally demonstrate the identity of fahl2 cDNA as encoding a hydroxylase that hydroxylates both oleic acid to produce ricinoleic acid to produce lesqueroic acid. These results also provide additional evidence that hydroxylase can be functionally expressed in a heterologous plant species in such a way that the enzyme is catalytically functional. These results also demonstrate that the expression of this hydroxylase gene leads to the accumulation of ricinoleic, lesqueroic, densipolic and auricolic acid in a plant species that does not normally accumulate hydroxylated fatty acids in extractable lipids. It is expected to find lesqueroic acid in transgenic plants based on biochemical evidence suggesting a broad substrate specificity of kappa-hydroxylase. In contrast, the accumulation of densipolic and auricolic acids was less predictable. Since Arabidopsis does not normally contain significant amounts of the non-hydroxylated precursors of these fatty acids that could serve as substrates for hydroxylase, it appears that one or more of the three n-3 fatty acid-desaturases known in Arabidopsis ( example, fad3, fad7, fad8; reviewed in Gibson et al. 1995) are capable of desaturating the hydroxy compounds at the n-3 position. That is, the densipolic acid is produced by the action of an n-3-desaturase in the ricinoleic acid. Auricolic acid is produced by the action of a n-3 desaturase in the lesquerólico acid. Because it is located in the endoplasmic reticulum, fad3 desaturase is almost certainly responsible. This can be tested in the future by producing transgenic plants containing fahl2 from the deficient mutant of fad3 from Arabidopsis (similar experiments can be done with fad7 and fad8), It is also formally possible that the enzymes that normally lengthen 18: lcis? 9 to 20 : lcisAl1 can lengthen 120H-18: lcisA9 to 14OH-20: lcisAl1 ', and 120H-18: 2cis? 9.i5 to i4oH-20: 2cis? 11'17. The amount of the various fatty acids in the lipids of the seeds, leaves and roots of the control and transgenic plants are also presented in Table 1. Although the amount of the hydroxylated fatty acids produced in this example is less than that desired for the production of ricinoleate and other hydroxylated fatty acids from plants, numerous improvements can be envisaged which will increase the level of accumulation of the hydroxylated fatty acids of plants expressing the fahl2 or related hydroxylase genes. Improvements in tissue level and specificity of hydroxylase gene expression are also envisioned. Methods for achieving this by the use of strong seed-specific promoters such as the napina promoter from B. napus will be obvious to one skilled in the art. Additional improvements are envisaged, including the modification of enzymes that cleave hydroxylated fatty acids from phosphatidylcholine, the reduction in the activities of enzymes that degrade hydroxylated fatty acids and the replacement of acyltransferases that transfer hydroxylated fatty acids to the sn-1, sn-2 and sn-3 positions of the glycerolipids. Although the genes for these enzymes have not been described in the scientific literature, their usefulness and improvement in the production level of hydroxylated fatty acids can be easily appreciated based on the results of the biochemical investigations of ricinoleate synthesis.
Although Arabidopsis is not an economically important plant species, it is widely accepted by plant biologists as a model for higher plants. Therefore, the inclusion of this example is proposed to demonstrate the general utility of the invention written here to the modification of the oil composition in higher plants. An advantage of studying the expression of this new gene in Arabidopsis is the existence of this system of a large body of knowledge in the metabolism of lipids, as well as the availability of a collection of mutants that can be used to provide useful information in the biochemistry of hydroxylation of fatty acids in plant species. Another advantage is the ease of the transposition of any information obtained in the metabolism of ricinoleate in Arabidopsis to closely related species such as the cultivars Brassica napus, Brassica júncea or Cra be abyssinica in order to mass produce ricinoleate, lesqueroleate or other hydroxylated fatty acids for industrial use. Kappa-hydroxylase is useful for the production of ricinoleate or leseroleate in any plant species that accumulates significant levels of precursors, oleic acid and icosenoic acid. Of particular interest are genetically modified varieties that accumulate high levels of oleic acid. These varieties are currently available for sunflower and cañola. The production of lesqueroic acid and related hydroxy fatty acids can be achieved in species that accumulate high levels of icosenoic acid or other long chain monoenoic acids. These plants can, in the future, be produced by genetic engineering of plants that do not normally elaborate these precursors. In this way, the use of kappa-hydroxylases will be of general utility.
EXAMPLE 2. ISOLATION OF THE GENETIC CLONE OF KAPPA-HIDR0XILA5A OF LESQUERELLA
General Appreciation
The regions of the nucleotide sequence that are retained in both the castor kappa-hydroxylase and the? 12 -fad2-fatty acid desaturase fad2 of Arabidopsis were used to design the oligonucleotide primers. These were used with genomic DNA from Lesquerella fendleri to amplify the fragments of several homologous genes. These amplified fragments were then used as hybridization zones to identify full-length genomic clones from a genomic library of L. fendleri. Hydroxylated fatty acids are specific to the seed tissue of Lesquerella sp, and are not found to any appreciable extent in plant tissues. One of the two genes identified by this method was expressed both in the leaves and in the developing seeds and is therefore thought to correspond to λ2 fatty acid-desaturase. The other gene was expressed at high levels in the seeds of development, but was not expressed or expressed at very low levels in the leaves and is the kappa-hydroxylase from this species. The identity of the gene as an acyl-fatty-hydroxylase was established by the functional expression of the gene in yeast. The identity of this gene was also established by introducing the gene into the transgenic plants of Arabidopsis and showing that it causes the accumulation of ricinoleic acid, lesqueroic acid, densipolic acid and auricolic acid and seed lipids.
The various steps involved in this process are described in detail later. Unless indicated otherwise, routine methods for manipulating nucleic acids, bacteria and phages were as described by Sambrook et al.
(1989).
Isolation of a fragment of the kappa-hydroxylase gene from Lesquerella
Oligonucleotide primers have been designed for the amplification of the kappa-hydroxylase of L. fendleri by choosing regions of high homology of the deduced amino acid sequence between the kappa-hydroxylase of castor and the? 12-desaturase of Arabidopsis (fad2) . Because most of the more are encoded by several codons, these oligonucleotides were designed to encode all possible codons that could code for the corresponding amino acids. The sequence where these mixed oligonucleotides were Oligo 1: TAYWSNCAYMGNMGNCAYCA (SEQ ID NO: 14) and Oligo 2: RTGRTGNGCNACRTGNGTRTC (SEQ ID NO: 15) where Y = C + T, W = A + T, S = G + C, N = A + G + C + 'T, M = A + C, and R = A + G.
These oligonucleotides were used to amplify a DNA fragment from the genomic DNA of L. fendleri by the polymerase chain reaction (PCR) using the following conditions: approximately 100 nm of genomic DNA was added to a solution containing 25 pmol of each primer, 1.5 U of Taq-polymerase (Boeheringer Manheim), 200 uM of dNTPs, 50 mM KCl, 10 mM Tris.Cl, (pH9), 0.1% (v / v) of Triton X-100, MgCl2 1.5 mM, 3% (v / v) of formamide, to a final volume of 50 μl. The amplification conditions were: denaturation step of 4 minutes at 94 ° C, followed by 30 cycles at 92 ° C for 1 minute, 55 ° C for 1 minute, 72 ° C for 2 minutes. A final extension step closed the program at 72 ° C for 5 minutes. PCR products of approximately 540 bp were observed after electrophoretic separation of the PCR reaction products on agarose gels. Two of these fragments were cloned into pBluescript (Stratagene) to elicit plasmids pLesq2 and pLesq3. The sequence of the inserts in these two plasmids was determined by the chain termination method. The sequence of the insert in pLesq2 is presented as Figure 5 (SEQ ID NO: 1) and the sequence of the insert in pLesq3 is presented as Figure 6 (SEQ ID NO: 2). The high degree of sequence identity between the indicated clones that were both potential candidates to be a? 12 desaturase or a kappa-hydroxylase.
Northern Analysis
In L. fendleri, hydroxylated fatty acids were found in large quantities in the seed oils but were not found in appreciable amounts in the leaves. An important criterion in the discrimination between an acyl-fatty-desaturase and the kappa-hydroxylase is that the kappa-hydroxylase gene is expected to be expressed more highly in tissues that have a higher level of hydroxylated fatty acids than in other tissues. In contrast, all tissues of the plant can contain mRNA for the 6-acyl-fatty-desaturase since the diunsaturated fatty acids are found in the lipids of all tissues in most or all plants. Therefore, it was of great interest to determine if the gene corresponding to pLesq2 was also expressed only in seeds or only expressed in other tissues. This question was proven by testing the hybridization of pLesq2 to purified RNA from developing and leaf seeds. Total RNA was purified from the developing seeds of the young leaves of L. fendleri using a Rneasy extraction kit (Qiagen), according to the manufacturer's instructions. RNA concentrations were quantified by UV spectrophotometry at α = 260 and 280 nm. In order to ensure uniform charging of the gel to be used for the Northern blotting, the RNA concentrations were further adjusted after recording the fluorescence under UV light of the RNA samples stained with ethidium bromide and runs on a gel Denaturing test. Total RNA prepared as described above from the developing leaves and seeds was subjected to electrophoresis through an agarose gel containing formaldehyde (Iba et al., 1993). An equal amount (10 μg) of the RNA was loaded into both cells, and RNA standards (0.16-1.77 kb scale, Gibco-BRL) were loaded into a third cell. After electrophoresis, the RNA was transferred from the gel to a nylon membrane (Hybond N +, Amersham) and fixed to the filter by exposure to UV light.
32 P-labeled probe was prepared from the insert DNA of clone pLesq2 by random priming and hybridized to the membrane overnight at 52 ° C, after which it had been prehybridized for 2 h. The prehybridization solution contained 5X SSC, 10X Denhardt solution, 0.1% SDS, 0.1 M KP04, pH 6.8, 100 μg / ml salmon sperm DNA. The hybridization solution had the same basic composition, but not SDS, and contained 10% dextran sulfate and 30% formamide. The transfer was washed once in 2X SSC, 0.5% SDS at 65 ° C, then in IX SSC at the same temperature. The brief exposure (30 minutes) of the transfer to the X-ray film revealed that the pLesq2 probe hybridized to an individual band only in the seed RNA cell (Figure 7). The transfer was re-probed with the insert from the en of pLesq3, which gave bands of similar intensity in the cells of the seed and leaves (Figure 7). These results show that the gene corresponding to the pLesq2 clone is expressed highly and specifically in the L. fendleri seeds. In conjunction with the knowledge of the deduced nucleotide and amino acid sequence, the strong specific expression of the seed of the gene corresponding to the insert in pLesq2 is a convincing indicator of the role of the enzyme in the synthesis of hydroxylated fatty acids in the oil of the seeds .
Characterization of a genomic clone of kappa-hydroxylase
Genomic DNA was prepared from young leaves of L. fendleri as described by Murray and Thompson (1980). A partial digestion genome library of Sau3AI constructed in the vector DashII (Stratagene, 11011 North Torrey Pines Road, La Jolla CA 92037) was prepared by partially digesting 500 μg of DNA, selecting by size the DNA in a viscous gradient (Sambrook and collaborators 1989), and by ligating the DNA (average size 12 kb) to the arms digested by Ba Hl from? DashII. The complete ligation was packaged according to the manufacturer's conditions and plated on E. coli strain SLl-Blue MRA-P2 (Stratagene). This produced 5 x 10 5 primary recombinant clones. The library was then amplified according to the conditions of the manufacturers. A fraction of the genomic library was plated on XLl-blue E. coli plates and the resulting plates (150,000) were lifted onto the loaded nylon membranes (Hybond N +, Amersham), according to the manufacturer's conditions. The DNA was crosslinked to the filters under UV in a Strata-linker (Stratagene). Several clones having the genomic sequences corresponding to L. fendleri hydroxylase were isolated by probing the membranes with the pLesq2 insert that was amplified by PCR with internal primers and labeled 32 P by random priming. The filters were prehybridized for 2 hours at 65 ° C in 7% SDS, 1 mM EDTA, 0.25 m Na2HP04 (pH 7.2), 1% BSA was hybridized to the probe for 16 hours in the same solution. The filters were washed sequentially at 65 ° C in solutions containing 2 x SSC, 1 x SSC, 0.5 X SSC in addition to 0.1% SDS. A fragment of 2.6 kb Xba containing the complete coding sequence for the kappa-hydroxylase and approximately 1 kb of the region in the 5 'direction was subcloned into the corresponding site of pBluescript KS to produce the plasmid pLewq-Hyd and the sequence it was completely determined using an automatic sequencer by the dideoxy chain termination method. The sequence data was analyzed using the DNASIS program (Hitachi Company).
The sequence of the insert in the pLesq-Hyd clone is shown in Figures 8A-B. The sequence brings with it 1855 bp of the contiguous DNA sequence (SEQ ID NO: 3). The clone encoded a 5 'untranslated region of 401 bp (ie, nucleotides preceding a first ATG codon, an open reading frame of 1152 bp, and a 3' untranslated region of 302 bp. open reading codes for a protein of 384 amino acids with a predicted molecular weight of 44,370 (SEQ ID NO: 4) .The term amino lacks the characteristics of a typical signal peptide (von Heijne, 1985) .The exact transduction methionine- initiation has not been determined experimentally, but based on the homology of the amino acid sequence deduced to the castor kappa-hydroxylase
(indicated below) is thought to be methionine encoded by the first ATG codon at nucleotide 402. The comparison of the deduced amino acid sequence of pLesq-Hyd with the sequences of membrane bound desaturases and castor hydroxylase (Figs. 9A-B) indicates that pLesq-Hyd is homologous to these genes. This figure shows an alignment of the hydroxylase of L. fendleri (SEQ ID NO: 4) with the castor hydroxylase (van de Loo et al., 1995), the fad2 cDNA of Arabidopsis coding for an α2-desaturase (so-called fad2) located in the endoplasmic reticulum (Okuley et al., 1994), two clones of soy fad2 desaturase, a fad2 clone of Brassica napus, a clone of fad2 of Zea mays and the partial sequence of a clone of Fad2 of an R communis. The high degree of homology of the sequence indicates that the gene products are of similar function. For example, the complete homology between the Lesquerella hydroxylase and the fad2 saturase of Arabidopsis was 92.2% similarity and 84.8% identity and the two sequences were different in length by only one amino acid.
Southern Hybridization
Southern analysis was used to examine the copy number of the genes in the L. fendleri genome corresponding to the pLesq-Hyd clone. The genomic DNA (5 μg) was digested with EcoRI, HindIII and Xbal and separated into a 0.9% agarose gene. The DNA was transferred alkaline to a loaded nylon membrane (Hybond N +, Amersham), according to the manufacturer's protocol. The transfer was prehybridized for 2 hours at 65 ° C in 7% SDS, 1 mM EDTA, 0.25 M Na2HP04 (pH 7.2) 1% BSA and was hybridized to the probe for 16 hours in the same solution with the pLesq insert. -Hyd amplified by PCR with internal primers and labeled with 32P by random priming. The filters were washed sequentially at 65 ° C in solutions containing 2 X SSC, 1 X SSC, 0.5 X SSC in addition to 0.1% SDS, then exposed to an X-ray film. The probe hybridized with an individual band at each DNA digestion of L. fendleri (Figure 10), indicating that the gene from which pLesq-Hyd was transcribed is present in an individual copy in the L. fendleri genome.
Expression of pLesq-Hyd in transgenic plants
There is a wide variety of plant promoter sequences that can be used to elicit tissue-specific expression of the cloned genes in the transgenic plants. For example, the napkin promoter and the acyl carrier protein promoters have previously used the modification of the seed oil composition by the expression of an antisense form of a desaturase (Knutson et al., 1992). Similarly, the promoter for the β-subunit of soy β-conglycinin has been shown to be highly active and results in specific expression of the residue in transgenic plants from species other than soybean. (Bray et al., 1987). In this manner, other promoters that drive seed specific expression can also be employed for the production of the modified seed oil composition. These modifications of the invention described herein will be obvious to one skilled in the art. Constructs for the expression of kappa-hydroxylase from L. fendleri in plant cells are prepared as follows: a Sali fragment of 13 kb containing the pLesq-Hyg gene was ligated into the Xhol site of the pSLJ44026 vector of Ti-plasmid binary (Jones et al., 1992) (Figure 11) to produce the plasmid pTi-Hyd and was transformed into the strains GV3101 of Agrobacterium tumefaciens by electroporation. Strain GV3101 (Koncz and Shell, 1986) contains a disarmed Ti-plasmid. The cells for electroporation were prepared as follows. The GV3101 was cultured in the LB medium with reduced NaCl (5 g / l).
A culture of 250 ml was grown at OD60o = 0.6, then centrifuged at 4000 rpm (Sorvall GS-A rotor) for 15 minutes. The supernatant was immediately aspirated from the loose pellet, which was redispersed gently in 500 ml of ice water. The cells were centrifuged as before, redispersed in 30 ml of ice-cold water, transferred to a 30 ml tube and centrifuged at 5000 rpm (Sorvall SS-34 rotor) for 5 minutes. This was repeated three times, the cells were redispersed consecutively in 30 ml of ice-cold water, 30 ml of 10% glycerol with ice, and finally in 0.75 ml of 10% glycerol cooled with ice. These cells were taken with aliquots, frozen in liquid nitrogen, and stored at -80 ° C. The electroporations used a Biorad Gene Pulser instrument using cold 2 mm separation specimens containing 40 μl of cells and 1 μl of DNA in water, at a voltage of 2.5 KV, and resistance of 200 Ohms. The cells subjected to electroporation were diluted with 1 ml of SOC medium
(Sambrook et al., 1989, page A2) and incubated at 28 ° C for 2-4 hours before plating in medium containing kanamycin (50 mg / l).
The Arabidopsis thaliana can be transformed with the Agrobacterium cells containing pTi-Hyd as described in Example 1 above. Similarly, the presence of the hydroxylated fatty acids in transgenic Arabidopsis plants can be demonstrated by the methods described in Example 1 above.
Constitutive expression of L. fendleri hydroxylase in transgenic plants
An EcoRI fragment of 1.5 kb from pLesq-Hyg comprising the complete coding region of the hydroxylase was gel purified, then cloned into the corresponding site of pBluescript KS (Stratagene). The plasmid DNA from a number of recombinant clones was then restricted with PstI, which must cut only once an insert and once in the polylinker sequence of the vector. The release of a 920 bp fragment with PstI indicated the correct orientation of the insert for further manipulations. The DNA from this clone was further restricted with Sali, the 5 'overhangs were filled in with the Klenow fragment of DNA polymerase I, then cut with Sacl. The insert fragment was gel purified, and cloned between the Smal and Sacl sites of pBI121 (Clontech) behind the 35S virus promoter from the cauliflower mosaic. After verifying that the sequence of the binding between the insert and the vector DNA was appropriate, the plasmid DNA from the recombinant clone was used to transform the A. tumefaciens (GV3101). The kanamycin-resistant colonies were then used for the in-plant transformation of A. thaliana as previously described. DNA was extracted from kanamycin-resistant small trees, and was used to PCR amplify selected fragments from the hydroxylase using the nested primers. When the fragments of the expected size could be amplified, the corresponding plants were grown in the greenhouse or oval plates, and the fatty acids were extracted from the fully spread leaves, roots and dry seeds. The GC-MS analysis was then performed as previously described to characterize the different fatty acid species and to detect the accumulation of hydroxy-fatty acids in the transgenic tissues.
Expression of Lesquerella hydroxylase in yeast
In order to demonstrate that the cloned L. fendleri gene encoded by a kappa-hydroxylase, the gene was expressed in yeast cells under the transcriptional control of an inducible promoter and the yeast cells were examined for the presence of the hydroxylated fatty acids by GS-MS. In a first step, the lambda genomic clone containing the L. fendleri hydroxylase gene was cut with EcoRI, and a resulting 1400 bp fragment containing the hydroxylase gene coding sequence was subcloned into the EcoRI site of the pBluescript vector KS (Stratagene). This subclone, pLesqco, contains the coding region of Lesquerella hydroxylase plus some additional 3 'sequence. In a second step, the pLesqcod was cut with HindIII and Xbal, and the insert fragment was cloned into corresponding sites of the yeast expression vector pYes2 (Invitrogen; Figure 12). This subclone, pLesqYes, contains the hydroxylase of L. fendleri in the homosense orientation relative to the 3 'side of the Gall promoter. This promoter is inducible by the addition of galactose to the culture medium, and is repressed in the glucose addition. In addition, the vector carries origins of replication that allow the propagation of pLesqYes in both yeast and E. coli.
Transformation of host strain CGY2557 of S. cerevisiae
The yeast strain CGY2557 (MATa, GAL +, ura3-52, leu2-3, trpl, ade2-l, lys2-l, his5, canl-100) was cultured overnight at 28 ° C in the liquid medium YPD (10 g of yeast extract, 20 g of bacto-peptone, 20 g of dextrose per liter) and an aliquot of the culture was inoculated into 100 ml of fresh YPD medium and cultured until the OD6oo of the culture was 1. Then, the cells they were collected by centrifugation and redispersed in approximately 200 μl of the supernatant. Aliquots of 40 μl of the cell suspension were then mixed with DNA 1-2 μg and subjected to electrophoresis in test pieces with a separation of 2 mm-gap using a Biorad Gene Pulser instrument adjusted to 600 V, 200 O, 25 μf, were added 160 μl of YPD and the cells were plated in the selective medium containing glucose. The selective medium consisted of 6.7 g of yeast nitrogen base
(Difco), 0.4 g of casamino acids (Difco), 0.02 g of adenine sulfate, 0.03 g of L-leucine, 0.02 g of L-tryptophan, 0.03 g of L-lysine-HCl, 0.03 of L-histidine-HCl, 2% glucose, water at 1 liter. The plates were solved using Difco Bacto-agar 1.5%. The transformant colonies appeared after 3 to 4 days of incubation at 28 ° C.
Expression of L. fendleri hydroxylase in yeast
The independent transformant colonies from the previous experiment were used to inoculate 5 ml of the selective medium containing either 2% glucose (repressed gene) or 2% galactose (induced gene) as the sole carbon source. The independent colonies of CGY2557 transformed with pYES2 that do not contain insert were used as controls. After 2 days of growth at 28 ° C, an aliquot of the cultures was used to inoculate 5 ml of the fresh selective medium. The new culture was placed at 16 ° C and cultivated for 9 days.
Analysis of yeast fatty acids expressing the hydroxylase of L. fendleri
Cells from 2.5 ml of the culture were pelleted at 1800 g, and the supernatant was aspirated as completely as possible. The pellets were then dispersed in 1 ml of 1 N methanolic HCl (Supelco, bellafonte, PA). The transmethylation and derivatization of the hydroxy fatty acids was performed as described above. After drying under nitrogen, the mixtures were redissolved in 50 μl of chloroform before they were analyzed by GC-MS. The samples were injected into a fused silica capillary column SP2330 (30 m X ID 0.25 mm, film thickness 0.25 μ, Supelco). The temperature profile was 100-160 ° C, 25 ° C / min, 160-230 ° C, 10 ° C / min, 230 ° C, 3 min, 230-100 ° C, 25 ° C / min. The flow rate was 0.9 ml / min. The fatty acids were analyzed using a mass spectrum detector of the 5971 series from Hewlett-Packard. The gas chromatograms of the methyl esters of the fatty acids derivatized from the induced cultures of yeast containing pLesqYes contained a new peak that eluted at 7.6 min (Figure 13). The O-TMS-methyl-ricinoleate eluted to exactly the same position in the control chromatograms. This peak was not present in cultures lacking pLesqYes or in cultures containing pLesqYes grown in glucose (control conditions) instead of lactose (induction conditions). The mass spectrometry of the peak (Figure 13) revealed that the peak has the same spectrum as O-TMS-methyl-ricinoleate. In this way, based on the chromatographic retention time and the mass spectrum, it was concluded that the peak corresponded to O-TMS-methyl-ricinoleate. The presence of ricinoleate in the transgenic yeast cultures confirms the entity of the gene as a kappa-hydroxylase of this invention.
EXAMPLE 3. OBTAINING OTHER PLANT ACIL-HYDROXYLASES
The castor fahl2 sequence can be used to identify other kappa-hydroxylases by methods such as PCR and heterologous hybridization. However, due to the high degree of sequence similarity between the γ2-desaturases u and the kappa-hydroxylases, the prior art does not teach how to distinguish between the two classes of enzymes without a functional test such as demonstrating activity in transgenic plants or another suitable host (e.g., microbial or animal cells, transgenic). The identification of the hydroxylase of L. fendleri provides the development of the criteria by which a hydroxylase and a desaturase can be distinguished solely on the basis of the deduced amino acid sequence information. Figures 9A-B show an alignment of the sequences of castor hydroxylase and L. fendleri with the castor hydroxylase sequence and all sequences publicly available for all 12 plant microsomal fatty acid desaturases. Of the 384 amino acid residues in the castor hydroxylated sequence, more than 95% are identical to the corresponding residue in at least one of the saturase sequences. Thus, none of these residues are responsible for the catalytic differences between hydroxylase and desaturases. Of the remaining 16 residues in castor hydroxylase and the 14 residues in Lesquerella 4 hydroxylase, the seven represent cases where the hydroxylase sequence has a conservative substitution compared to one or more of the desaturase sequences, or there is extensive variability in the amino acid at that position in the various desaturases. By conservative, it can be said that the following amino acids are functionally equivalent: Ser / Thr, Ile / Leu / Val / Met, Asp / Glu. These structural differences also can not account for the catalytic differences between desaturases and hydroxylases. This leaves only seven amino acid residues where the castor hydroxylase and Lesquerella hydroxylase differ from all known desaturases and where all known microsomal 12-desaturases have the identical amino acid residue. These residues are presented in positions 69, 111, 155, 226, 304, 331 and 333 of the alignment in Figure 9. Therefore, these seven sites distinguish hydroxylases from desaturases. Based on this analysis, it is believed that any enzyme with more than 60% sequence identity to one of the enzymes listed in Figure 9 can be classified as a hydroxylase is deferred from the sequence of the desaturases in these seven positions. Due to the slight differences in the number of residues in a particular protein, the numbering may vary from protein to protein but the intent of the number system will be evident if the protein in question is aligned with the castor hydroxylase using the numbering system shown in the present. Thus, in conjunction with methods for using the Lesquerella hydroxylase gene to isolate the homologous genes, the structural criteria described herein teach how to isolate and identify the plant kappa-hydroxylase genes for the purpose of genetically encoding the fatty acid composition as described herein.
EXAMPLE 4. USE OF HYDROXYLASE TO ALTER THE NUTRITION OF THE INSATURATION OF FATTY ACIDS
The evidence that the kappa-hydroxylases of this invention can be used to alter the saturation level of the fatty acids, was obtained from the analysis of the transgenic plants expressing the castor hydroxylase under the control of the mosaic virus promoter. of the cauliflower. The construction of the plasmids and the production of the transgenic Arabidopsis plants are described in Example 1 (above). The fatty acid composition of the wild-type seed lipids and six transgenic lines (1-2 / a, 1-2 / b, 1-3 / b, 4F, 7E, 7F) is shown in Table 2 .
Table 2. Fatty acid composition of lipids from the Arabidopsis seed. The asterist (*) indicates that for some of these samples, the peaks 18: 3 and 20: 1 superimposed on the gas chromatogram and therefore, the total amount of these two fatty acids is reported.
r-n
The results in Table 2 show that expression of the castor hydroxylase in the transgenic Arabidopsis plants caused a substantial increase in the amount of oleic acid (18: 1) in the lipids of the seeds and a correspondingly corresponding decrease in the amount of linoleic acid (18: 2). The average amount of oleic acid in the six transgenic lines was 29.9% versus 14.7% in the wild type. No precise mechanism is known by which the expression of the castor hydroxylase gene causes the increased accumulation of oleic acid. However, an increase in the mechanism is not required in order to exploit this invention for the direct alteration of the fatty acid composition of plant lipids. Additionally, it will be recognized by one skilled in the art that many improvements of this invention can be anticipated. Of particular interest will be the use of other promoters that have high levels of seed-specific expression. Since the hydroxylated fatty acids were not detected in the lipids of the seeds of the l-2b transgenic line, it seems likely that it is not the presence of hydroxylated fatty acids per se that causes the effect of the castor hydroxylase gene on activity. of the desaturasas. The protein-protein interaction between the hydroxylase and the? 12-oleate-desaturase or other protein may be required for the complete reaction (eg, cytochrome b5) or for the regulation of the desaturases activity. For example, the interaction between hydroxylase and this other protein can suppress the activity of the desaturase. In particular, the quaternary structure of the desaturases bound to the membrane has not been established. It is possible that these enzymes are active as dimers or as multimeric complexes containing more than two subunits. Thus, if the dimers or multimers are formed between the desaturase and the hydroxylase, the presence of the hydroxylase in the complex can break down the activity of the desaturase. Transgenic plants can be produced in which the hydroxylase enzyme has become inactive by the removal of one or more of the histidine residues that have been proposed that bind the iron molecules required for catalysis. Several of these histidine residues have been shown to be essential for the activity of the desaturase by sequence-directed mutagenesis (Shanklin et al., 1994). The codons coding for the histidine residues in the castor hydroxylase gene will be changed to alanine residues, as described by Shanklin et al. (1994). The modified genes will be introduced into transgenic Arabidopsis plants, and possibly other species such as tobacco, by the methods described in Example 1 of this application. In order to examine the effect on all tissues, the strong promoter of the constitutive cauliflower mosaic virus can be used to elicit transcription of the modified genes. Nevertheless, it will be recognized that in order to specifically examine the effect of mutant gene expression on seed lipids, a seed-specific promoter such as the napina promoter from B. napus can be used. An expected result is that the expression of the inactive hydroxylase protein in the transgenic plants will inhibit the activity in the? 12-desaturase located in the endoplasmic reticulum. Maximum inhibition will be obtained by expressing high levels of the mutant protein. In a further embodiment of this invention, mutations that inactivate other hydroxylases, such as the Lesquerella hydroxylases of this invention, may also be useful for decreasing the amount of α12 activity located in the endoplasmic reticulum in the same manner as the castor gene. In a further embodiment of this invention, many similar genes of the desaturase genes can also be used to inactivate the endogenous desaturases. In this way, the expression of the catalytically inactive fad2 gene from Arabidopsis in the transgenic Arabidopsis can inhibit the activity of the endogenous fad2 gene product. Similarly, the expression of the catalytically inactive forms of the? 2-desaturase from Arabidopsis or other plants in transgenic soybeans, naba, crambe, brassica júncea, cañola, flax, sunflower, safflower, cotton, cuphea, soybean, peanut , coconut, oil or corn core can condition the inactivation of endogenous? 12-desaturase activity in these plants. In a further embodiment of this invention, the expression of the catalytically inactive forms of other desaturases such as α5-desaturases can lead to the inactivation of the corresponding desaturases. An example of a class of mutants useful in the present invention are the "negative, dominant" mutants that block the function of a gene at the protein level (Herskowitz, 1987). A cloned gene is altered so that it encodes a mutant product capable of inhibiting the wild-type gene product in a cell, thereby causing the cell to be deficient in the function of that gene product. Inhibitory variants of a wild-type product can be designed because the proteins have multiple functional domains that can be independently mutated, for example, oligomerization, substrate binding, catalysis, membrane association domains or the like. In general, the dominant negative proteins retain the functional subset, intact from the wild-type protein domains, of origin, but the complete subunit of that subunit that is deleted or altered to be nonfunctional. Whichever is the precise basis for the inhibitory effect of castor hydroxylase on desaturation, because castor hydroxylase has very low homology of the nucleotide sequence (ie, approximately 67%) to the fad2 gene of Arabidopsis (which codifies for the? 2-desaturase located in the endoplasmic reticulum), the inhibitory effect of this gene, which is tentatively called "protein-mediated inhibition"
("protohibition"), may have wide utility because it does not depend to a greater degree on the homology of the nucleotide sequence between the transgene and the endogenous target gene. In particular, castor hydroxylase can be used to inhibit the activity of the? 2-desaturase located in the endoplasmic reticulum of higher plants. Of particular interest are those species used for oil production. These include, but are not limited to: Naba, Crambe, Brassica Júncea, cañola, flax, sunflower, safflower, cotton, cuphea, soy, peanut, coconut, corn oil cream.
CONCLUSION NOTES
By the above examples, the demonstration of critical factors in the production of new hydroxy fatty acids by the expression of a kappa-hydroxylase gene from castor in transgenic plants is described. In addition, a complete kappa-hydroxylase cDNA sequence from Lesquerella fendleri is also provided. A complete sequence of the castor hydroxylase is also given with various constructs for use in host cells.
Through this invention, the amino acid and nucleic acid sequences encoding the plant acyl-fatty-hydroxylases can be obtained from a variety of sources and for a variety of applications. Also pertinent is a new method by which the level of fatty acid desaturation can be altered in a direct way through the use of genetically altered genes of hydroxylase or desaturase. All the publications mentioned in this specification are indicative of the level of the person skilled in the art to which this invention corresponds. All publications are incorporated herein by reference to the same degree as if each individual publication was specifically and individually indicated to be incorporated by reference. Although the above invention has been described in some detail by way of illustration and by way of example for purposes of clarity and understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.
REFERENCES
Arondel, V., B. Lemieux, I. Hwang, S. Gibson, H. Goodman, C.R. Somerville. Map-based cloning of a gene controlling omega-3 fatty acid desaturation in Arabidopsis. Science 258, 1353-1355 (1992).
Ats on, D. (1989) Beaver, in Oil Crops of the World Robbelen, G., Downey, K.R., and Ashri, A., Eds., McGraw-Hill, New York p. 438-447.
Bechtold, N., Ellis, J. and Pelletier, G. (1993) In Plant Agrobacterium mediated gene transfer by infiltration of adult Arabidopsis thaliana plants. C.R. Acad. Sci. Paris 316, 1194-1199.
Beltz, G.A., Jacobs, K.A., Eickbuch, T.H., Cherbas, P.T., Kafatos, F.C. (1983) Isolation of multigene families and determination of homologies by filter hybridization methods. Methods in Enzymology 100, 266-285.
Bray, E.A., Naito, S., Pan, N.S., Anderson, E., Dube, P., Beachy, R.N. (1987) Expression of the ß-subunit of ß-conglycinin in seeds of transgenic plants. Plant 172, 364-370.
Carlson, K.D., Chaudhry, A., Bagby, M.O (1990) Analysis of oil and meal from lesquerella fendleri seed. J. Am. Oil Chem. Soc. 67, 438-442.
Ditta, G., Stanfield, S., Corbin, D., Helinski, D.R. (1980) Broad host range DNA cloning system for gram-negative bacteria: Construction of a gene bank of Rhizobium meliloti. Proc. Nati Acad. Sci. USA 77, 7347-7351.
Gibson, S., Arondel, V., Iba, K., Somerville, C.R. (1994) Temperature Regulated Expression of a Gene Encoding to Chloroplast omega-3 Desaturase from Aratidopsis thaliana. Plant Physiol. 106, 1615-1621.
Gould, S.J., Subra ani, S., Scheffler, I.E. (1989) Use of the DNA polymerase chain reaction for homology probing. Proc. Nati Acad. Sci. USA 86, 1934-1938.
Herskowitz, I. (1987) Functional inactivation of genes by dominant negative mutations. Nature 329, 219-222.
Hirsinger, F. (1989) New oil crops, in Oil Crops of the World, Robbelen, G., Downey, K.R., and Ashri, A., Eds., McGraw-Hill, New York, pp. 518-533.
Howling, D., Morris, L.J., Gurr, M.I., James, A.T. (1972) The specificity of fatty acid desaturases and hydroxylases. The dehydrogenation and hydroxylation of monoenoic acids, Biochim. Biophys. Acta 260, 10
Huyuh, T.V., Young, R.A., Davis, R.W. (1985) Constructing and screening cDNA libraries in AgtlO and kgEll. In DNA Cloning, Vol. 1: A Practical Approach, (ed.) D.M. Glover. IRL Press, Washington DC pp 49-77.
Iba, K., Gibson, S., Nishiuchi, T., Fuse, T., Nishimura, M., Arondel, V., Hugly, S., and Somerville, C. (1993) A gene encoding a chloroplast omega- 3 fatty acid desaturase complements alterations in fatty acid desaturation and chloroplast copy number of the fad7 mutant of Arabidopsis thaliana. J. Biol. Chem. 268, 24099-24105.
Jones, JDG, Shlum.ukov, L., Carland, F., English, J., Scofield, S., Bishop, GJ, Harrison, K. (1992) Effective vectors for transformation, expression of heterologous genes, and assaying transposon excision in tranegenic plants. Transgenic Res. 1, 285-297.
Knutson, D.S., Thompson, G.A., Radke, S.E., Johnson, W.B., Knauf, V.C., Kridl, J.C. (1992) Proc. Nati Acad. Sci. USA 89, 2624-2628.
Koncz, C, Schell, J. (1986) The promoter of TL-DNA gene 5 controls the tissue-specific expression of chimeric genes carried out by a novel type of Agrobacterium binary vector. Mol. Gen. Genet. 204, 383-396.
Matzke, M., Matzke, A.J.M. (1995) How and why do plants inactivate homologous (Trans) genes? Plant Physiol. 107, 679-685.
Miquel, M. Browse, J. (1992) Arabidopsis mutants deficient in polyunsaturated fatty acid synthesis. J. Biol. Chem. 267, 1502-1509.
Murray, M.G., Thompson, W.F. (1980) Rapid isolation of high molecular weight plant DNA. Nucí Acid Res. 8, 4321-4325.
Okuley, J., Lightner, J., Feldman, K., Yadav, N., Lark, E., Browse, J. (1994) Arabidopsis FAD2 gene *
encodes the enzyme; hat is essential for polyunsaturated iipid. Plant Cell 6, 147-158.
Sambrook, J., Fritsch, E.F., and Maniatis, T., 5 Molecular Cloning: a fabora tory Manual, 2nd ecl., Cold Spring Harbor Laboratory Press, 1989.
Shanklin, J., Whittle, E., Fox, B.G. (1994) Eight histidine residues are catalytically essential in a 10 membrane-associated iron enzyme, stearoyl-CoA desaturase, and are conserved in alkane hydroxylase and xylene monoxygenase. Biochemistry 33, 12787-12794.
Smith, C.R., Jr. (1985) Unusual seed oils and their 15 fatty acids, in Fatty Acids, Pryde E.H., Ed., American Oil Chemists' Society, Champaign, Second edition, pp. 29-47.
Topfer, R., Martini, N., Schell, J. (1995) 20 Modification of plant lipid synthesis. Science 268, 681-686.
van de Loo, F.J., Fox, B.G., Somerville, C. (1993) Unusual fatty acids, in Lipid Metabolis in Plants, 25 T.S. Moore Jr. , Ed., CRC Press, Boca Raton, pp 91-126.
van de Loo, F.N., Turner, S., Somerville, C.R. (1995, An Léate 12-nydroxylase fro * castor (Rlclnus co ^ unls L. l ls fatty aoyl desaturase no olog. Proc.
Nati Acad -. cS ^ cii. TUTbAA 9y2¿ ,, 6743-6747.
".. r (1985) Signal sequences. J. Mol. Biol. Von Hei ne, G. 1 ^ 0D '° and 194, 99-105.
LIST OF SEQUENCES
(1) GENERAL INFORMATION (i) APPLICANT: Somerville, Chris Broun, Pierre Van de Loo, Frank Boddupalli, Sekhar S.
(ii) TITLE OF THE INVENTION: Production of Hydroxylated Fatty Acids in Genetically Modified Plants (iii) SEQUENCE NUMBER: 15
(iv) CORRESPONDENCE ADDRESS: (A) RECIPIENT: PILLSBURY MADISON & SUTRO
(B) STREET: 1100 NEW YORK AVENUE, N.W. (C) CITY: WASHINGTON (D) STATE: D.C. (E) COUNTRY: USA (F) POSTAL CODE: 20005-3918
(v) COMPUTER LEGIBLE FORM: (A) TYPE OF MEDIA: Flexible disk (B) COMPUTER: compatible with IBM PC (C) OPERATING SYSTEM: DOS 5.0 (D) PROGRAM: Word Perfect 5.1
(vi) DATA OF THE CURRENT APPLICATION: (A) APPLICATION NUMBER: has not been assigned (B) DATE OF SUBMISSION: February 6, 1997
(C) CLASSIFICATION:
) INFORMATION FOR SEQ ID NO: l:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 543 nucleotides (B) TYPE: nucleotide (C) TYPE OF HEBRA: simple D) TOPOLOGY: linearPTION FOR SEQ. ID No: 1:
TATTGGCACC GGCGGCACCÁ TTCCAACAAT GGATCCCTAG_40_AAAAAGATGA AGTCTTTGTC CCACCTAAGA AAGCTGCAGT 80
CANATGGTAT GTCAAATACC TCAACAACCC TCTTGGACGC 120
ATTCTGGTGT TAACAGTTCA GTTTATCCTC GGGTGGCCTT 160 TGTATCTAGC CTTTAATGTA TCAGGTAGAC CTTATGATGG 200
TTTCGCTTCA CATTTCTTCC CTCATGCACC TATCTTTAAG 240
GACCGTGAAC GTCTCCAGAT ATACATCTCA GATGCTGGTA 2 80
TTCTAGCTGT CTGTTATGGT CTTTACCGTT ACGCTGCTTC 320
ACAAGGATTG ACTGCTATGA TCTGCGTCTA CGGAGTACCG 3 60
CTTTTGATAG TGAACTTTTT CCTTGTCTTG GTCACTTTCT 400
TGCAGCACAC TCATCCTTCA TTACCTCACT ATGATTCAAC 440
CGAGTGGGAA TGGATTAGAG GAGCTTTGGT TACGGTAGAC 480
AGAGACTATG GAATCTTGAA CAAGGTGTTT CACAACATAA 520
CAGACACCCA CGTAGCACAC CAC. 543
(2) INFORMATION FOR SEQ ID NO: 2:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 544 nucleotides s (B) TYPE: nucleotide (C) TYPE OF HEBRA: simple (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 2:
TATAGGCACC GGAGGCACCA TTCCAACACA GGATCCCTCG 40
AAAGAGATGA AGTATTTGTC CCAAAGCAGA AATCCGCAAT BO
CAAGTGGTAC GGCGAATACC TCAACAACCC TCCTGGTCGC 120
ATCATGATGT TAACTGTCCA GTTCGTCCTC GGATGGCCCT 160
TGTACTTAGC CTTCAACGTT TCTGGCAGAC CCTACAATGG 200
TTTCGCTTCC CATTTCTTCC CCAATGCTCC TATCTACAAC 240
GACCGTGAAC GCCTCCAGAT TTACATCTCT GATGCTGGTA 280
TTCTAGCCGT CTGTTATGGT CTTTACCGTT ACGCTGTTGC 320
ACAAGGACTA GCCTCAATGA TCTGTCTAAA CGGAGTTCCG 360
CTTCTGATAG TTAACTTTTT CCTCGTCTTG ATCACTTACT 400
TACAACACAC TCACCCTGCG TTGCCTCACT ATGATTCATC 440
AGAGTGGGAT TGGCTTAGAG GAGCTTTAGC TACTGTAGAC 48 0
AGAGACTATG GAATCTTGAA CAAGGTGTTC CATAACATCA 520
CAGACACCCA CGTCGCACAC CACT 544
(2) INFORMATION FOR SEQ ID NO: 3:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 1855 nucleotides (B) TYPE: nucleotide (C) TYPE OF HEBRA: simple (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 3:
ATGAAGCTTT ATAAGAAGTT AGTTTTCTCT GGTGACAGAG 40
AAATT TGTC AATTGGTAGT GACAGTTGAA GCAACAGGAA 80
CAACAAGGAT GGTTGGTGNT GATGCTGATG TGGTGATGTG 120
TTATTCATCA AATACTAAAT ACTACATTAC TTGTTGCTGC 160
CTACTTCTCC TATTTCCTCC GCCACCCATT TTGGACCCAC 200
GANCCTTCCA TTTAAACCCT CTCTCGTGCT ATTCACCAGA 240
AGAGAAGCCA AGAGAGAGAG AGAGAGAATG TTCTGAGGAT 280
CATTGTCTTC TTCATCGTTA TTAACGTAAG TTTTTTTTGA 320
CCACTCATAT CTAAAATCTA GTACATGCAA TAGATTAATG 360
ACTGTTCCTT CTTTTGATAT TTTCAGCTTC TTGAATTCAA 400
GATGGGTGCT GGTGGAAGAA TAATGGTTAC CCCCTCTTCC 440
AAGAAATCAG AAACTGAAGC CCTAAAACGT GGACCATGTG 480
AGAAACCACC ATTCACTGTT AAAGATCTGA AGAAAGCAAT 520
CCCACAGCAT TGTTTCAAGC GCTCTATCCC TCGTTCTTTC 560
TCCTACCTTC TCACAGATAT CACTTTAGTT TCTTGCTTCT 600
ACTACGTTGC CACAAATTAC TTCTCTCTTC TTCCTCAGCC 640
TCTCTCTACT TACCTAGCTT GGCCTCTCTA TTGGGTATGT 680
CAAGGCTGTG TCTTAACCGG TATCTGGGTC ATTGGCCATG 72C
AATGTGGTCA CCATGCATTC AGTGACTATC AATGGGTAGA 760
TGACACTGTT GGTTTTATCT TCCATTCCTT CCTtCTCGTC 800
CCTTACTTCT CCTGGAAATA CAGTCATCGT CGTCACCATT 840
CCAACAATGG ATCTCTCGAG AAAGATGAAG TCTTTGTCCC 880
ACCGAAGAAA GCTGCAGTCA AATGGTATGT TAAATACCTC 920
AACAACCCTC TTGGACGCAT TCTGGTGTTA ACAGTTCAGT 960
TTATCCTCGG GTGGCCTTTG TATCTAGCCT TTAATGTATC 100O
AGGTAGACCT TATGATGGTT TCGCTTCACA TTTCTTCCCT 1040
CATGCACCTA TCTTTAAAGA CCGAGAACGC CTCCAGATAT 1080
ACATCTCAGA TGCTGGTATT CTAGCTGTCT GTTATGGTCT 1120
TTACCGTTAC GCTGCTTCAC AAGGATTGAC TGCTATGATC 1160
TGCGTCTATG GAGTACCGCT TTTGATAGTG AACTTTTTCC 1200
TTGTCTTGGT AACTTTCTTG CAGCACACTC ATCCTTCGTT 1240
ACCTCATTAT GATTCAACCG AGTGGGAATG GATTAGAGGA 1280
GCTTTGGTTA CGGTAGACAG AGACTATGGA ATATTGAACA 1320
AGGTGTTCCA TAACATAACA GACACACATG TGGCTCATCA 1360
TCTCTTTGCA ACTATACCGC ATTATAACGC AATGGAAGCT 1400
ACAGAGGCGA TAAAGCCAAT ACTTGGTsAT TACTACCACT 1440
TCGATGGAAC ACCGTGGTAT GTGGCCATGT ATAGGGAAGC 1480
AAAGGAGTGT CTCTATGtAG AACCGGATAC GGAACGTGGG 1520
AAGAAAGGTG TCTACTATTA CAACAATAAG TTATGAGGCt 1560
GATAGGGCGA GAGAAGTGCA ATTATCAATC TTCATTTCCA 1600
TGTTTTAGGT GTCTTGTTTA AGAAGCTATG CTTTGTTTCA 16 0
ATAATCTCAG AGTCCATNTA GTTGTGTTCT GGTGCATTTT 1680 GCCTAGTTAT GTGGTGTCGG AAGTTAGTGT TCAAACTGCT 1720CTGCCCAGTG AAGAACAAGT TTACGTGTTT 1760
AAAATACTCG GAACGAATTG ACCACAANAT ATCCAAAACC 1800
GGCTATCCGA ATTCCATATC CGAAAACCGG ATATCCAAAT 1840
TTCCAGAGTA CTTAG_1855_) INFORMATION FOR SEQ ID NO: 4:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 384 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 4:
Met Gly Ala Gly Gly Arg He Met Val Thr 5 10
Pro Ser Ser Lys Lys Ser Glu Thr Glu Wing 15 20
Leu Lys Arg Gly Pro Cys Glu Lys Pro Pro 25 30
Phe Thr Val Lys Asp Leu Lys Lys Wing He 35 40
Pro Gln His Cys Phe Lys Arg Ser He Pro 45 50
Arg Ser Phe Ser Tyr Leu Leu Thr Asp He 55 60
Thr Leu Val Ser Cys Phe Tyr Tyr Val Wing 65 70
Thr Asn Tyr Phe Ser Leu Leu Pro Gln Pro 75 80
Leu Ser Thr Tyr Leu Wing Trp Pro Leu Tyr 85 90
Trp Val Cys Gln Gly Cys Val Leu Thr Gly 95 100
lie Trp Val lie Gly His Glu Cys Gly His 105 110
H s Wing Phe Ser Asp Tyr Gln Tm Val Asp 115 '120
Asp Thr Val Gly Phe lie Phe His Ser Phe '125 130
Leu Leu Val Pro Tyr Phe Ser Trp Lys Tyr 135 140
Ser His Arg Arg His His Ser Asn Asn Gly 145 150
Ser Leu Glu Lys Asp Glu Val Phe Val Pro 155 160
Pro Lys Lys Ala Wing Val Lys Trp Tyr Val 165 170
Lys Tyr Leu Asn Asn Pro Leu Gly Arg He 175 180
Leu Val Leu Thr Val Gln Phe lie Leu Gly 185 190
Trp Pro Leu Tyr Leu Wing Phe Asn Val Ser 195 200
Gly Arg Pro Tyr Asp Gly Phe Ala Ser His 205 210
Phe Phe Pro His Wing Pro lie Phe Lys Asp 215 220
Arg Glu Arg Leu Gln He Tyr He Ser Asp • 225 230
Ala Gly He Leu Ala Val Cys Tyr Gly Leu 235 240
Tyr Arg Tyr Ala Ala Ser Gln Gly Leu Thr 245 250
Wing Met He Cys Val Tyr Gly Val Pro Leu 255 260
Leu Hem Val Asn Phe Phe Leu Val Leu Val 265 270 Thr Phe Leu Gln His Thr His Pro Ser Leu 275 280
Pro His Tyr Asp Ser Thr Glu Trp Glu Trp 285 290
He Arg Gly Ala Leu Val Thr Val Asp Arg 295 300
Asp Tyr Gly He Leu Asn Lys Val Phe His 305 310
Asn He Thr Asp Thr His Val Wing His His 315 '320
Leu Phe Ala Thr He Pro His Tyr Asn Ala 325 330
• Met Glu the Thr Glu Ala He Lys Pro He 335 340
Leu Gly Asp Tyr Tyr His Phe Asp Gly Thr 345 350
Pro Trp Tyr Val Wing Met Tyr Arg Glu Wing 355 360
Lys Glu Cys Leu Tyr Val Glu Pro Asp Thr 365. 370
Glu Arg Gly Lys Lys Gly Val Tyr Tyr Tyr 375 380
Asn Asn Lys Leu
ORMATION FOR SEQ ID NO: 5:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 387 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 5:
Met Gly Gly Gly Gly Arg Met Ser Thr Val 5 10 He Thr Ser Asn Asn Ser Glu Lys Lys Gly 15 20
Gly Ser Ser His Leu Lys Arg Ala Pro His 25 30
Thr Lys Pro Pro Phe Thr Leu Gly Asp Leu 35 40
Lys Arg Ala He Pro Pro His Cys Phe Glu 45 50
Arg Ser Phe Val Arg Ser Phe Ser Tyr Val 55 60
Wing Tyr Asp Val Cys Leu Ser Phe Leu Phe 65 70
Tyr Ser He Wing Thr Asn Phe Phe Pro Tyr 75 80
I Ser Ser Pro Leu Ser Tyr Val Ala Trp 85 90
Leu Val Tyr Trp Leu Phe Gln Gly Cys He 95 100
Leu Thr Gly Leu Trp Val He Gly His Glu 105 110
Cys Gly His His Wing Phe Ser Glu Tyr Gln 115 120
Leu Ala Asp Asp He Val Gly Leu He Val 125 130
His Ser Ala Leu Leu Val Pro Tyr Phe Ser 135 140
Trp Lys Tyr Ser His Arg Arg His His Ser 145 150
Asn He Gly Ser Leu Glu Arg Asp Glu Val 155 160
Phe Val Pro Lys Ser Lys Ser Lys He Ser 165 170
Trp Tyr Ser Lys Tyr Ser Asn Asn Pro Pro 175 180
Gly Arg Val Leu Thr Leu Ala Wing Thr Leu 185 190 Leu Leu Gly Trp Pro Leu Tyr Leu Wing Phe 195 200
Asn Val Ser Gly Arg Pro Tyr Asp Arg Phe 205 210
Ala Cys His Tyr Asp Pro Tyr Gly Pro He 215 220
Phe Ser alu Arg Glu Arg Leu Gln He Tyr 225 230
He Wing Asp Leu Gly He Phe Wing Thr Thr 235 240
Phe Val Leu Tyr Gln Ala Thr Met Ala Lys 245 250
Gly Leu Wing Trp Val Met Arg He Tyr Gly 255 260
Val Pro Leu Leu He Val Asn Cys Phe Leu 265 270
Val Met He Thr Tyr Leu Gln His Thr His 275 280
Pro Ala He Pro Arg Tyr Gly Ser Ser Glu 285 290
Trp Asp Trp Leu Arg Gly Wing Met Val Thr 295 300
Val Asp Arg Asp Tyr Gly Val Leu Asn Lys 305 310
Val Phe His Asn He Wing Asp Thr His Val 315 320
Ala His His Leu Phe Ala Thr Val Pro His 325 330
Tyr His Wing Met Glu Wing Thr Ly9 Wing He 335 335
Lys Pro He Met Gly Glu Tyr Tyr Arg Tyr 345 350
A = p Gly Thr Pro Phe T / r Lys Ala Leu Trp 355 360 Arg Glu Ala Lys Glu Cys Leu Phe Val Glu 365 370
Pro Asp Glu Gly Wing Pro Thr Gln Gly Val 375 380
Phe Trp Tyr Arg Asn Lys Tyr 385
ORMATION FOR SEQ ID NO: 6:
i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 383 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 6:
Met Gly Wing Gly Gly Arg Met Pro Val Pro 5 10
Thr Ser Ser Lys Lys Ser Glu Thr Asp Thr 15 20
Thr Lys Arg Val Pro Cys Glu Lys Pro Pro 25 30
Phe Ser Val Gly Asp Leu Lys Lys Ala He 35 40
Pro Pro His Cys Phe Lys Arg Ser He Pro 45 50
Arg Ser Phe Ser Tyr Leu He Ser Asp He 55 60
He He Wing Being Cys Phe Tyr Tyr Val Wing 65 70
Thr Asn Tyr Phe Ser Leu Leu Pro Gln Pro 75 80
Leu Ser Tyr Leu Wing Trp Pro Leu Tyr Trp 85 90
Ala Cys Gln Gly Cys Val Leu Thr Gly He 95 100
Trp Val He Ala His Glu Cys Gly His His 105 110
Wing Phe Ser Asp Tyr Gln Trp Leu Asp Asp 115 120
Thr Val Gly Leu He Phe His Ser Phe Leu 125 130
Leu Val Pro Tyr Phe Ser Trp Lys Tyr Ser 135 140
His Arg Arg His His Ser Asn Thr Gly Ser 145 150
Leu Glu Arg Asp Glu Val Phe Val Pro Lys 155 160
Gln Lys Ser Ala He Lys Trp Tyr Gly Lys 165 170
Tyr Leu Asn Asn Pro Leu Gly Arg He Met 175 180
Met Leu Thr Val Gln Phe Val Leu Gly Trp '185 190
Pro Leu Tyr Leu Ala Phe Asn Val Ser Gly 195 200
Arg Pro Tyr Asp Gly Phe Ala Cys His Phe 205 210
Phe Pro Asn Ala Pro He Tyr Asn Asp Arg 215 220
Glu Arg Leu Gln He Tyr Leu Ser Asp Ala 225 230
Gly He Leu Wing Val Cys Phe Gly Leu Tyr 235 240
Arg Tyr Ala Ala Ala Gln Gly Met Ala Ser 245 250
Met He Cys Leu Tyr Gly Val Pro Leu Leu 255 260
He Val Asn Ala Phe Leu Val Leu He Thr 265 270
Tyr Leu Gln His Thr His Pro Ser Leu Pro 275 280 His Tyr Asp Ser Ser Glu Trp Asp Trp Leu 285 290 Arg Gly Wing Leu Wing Thr Val Asp Arg Asp 295 300 Tyr Gly He Leu Asn Lys Val Phe His Asn 305 310 He Thr Asp Thr His Val Ala His His Leu 315 320 Phe Ser Thr Met Pro His Tyr Asn Ala Met 325 330 Glu Ala Thr Lys Ala He Lys Pro He Leu 335 340 Gly Asp Tyr Tyr Gln Phe Asp Gly thr Pro 345 350 Trp Tyr Val Ala Met Tyr Arg Glu Ala Lys 355 360 Glu Cys He Tyr Val Glu Pro Asp Arg Glu 365 370 Gly Asp Lys Lys Gly Val Tyr Trp Tyr Asn 375 380 Asn Lys Leu
2) INFORMATION FOR SEQ ID NO: 7:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 384 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: 10 (D) TOPOLOGY: linear (xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 7
Met Gly Wing Gly Gly Arg Met.Gln Val Ser 5 10 Pro Pro Ser Lys Lys Ser Glu Thr Asp Asn 15 20 He Lys Arg Val Pro Cys Glu Thr Pro Pro 25 30
Phe Thr Val Gly Glu Leu Lys Lys Ala He 35 40
Pro Pro His Cys Phe Lys Arg Ser He Pro 45 50
Arg Ser Phe Ser His Leu He Trp Asp He 55 60
He He Wing Being Cys Phe Tyr Tyr Val Wing 65 70
Thr Thr Tyr Phe Pro Leu Leu Pro Asn Pro 75: 80
Leu Ser Tyr Phe Wing Trp Pro Leu Tyr Trp 85 90
Ala Cys Gln Gly Cys Val Leu Thr Gly Val 95 100
Trp Val He Ala His Glu Cys Gly His Ala 105 110
Wing Phe Ser Asp Tyr Gln Trp Leu Asp Asp 115 120
Thr Val Gly Leu He Phe His Ser Phe Leu 125 130
Leu Val Pro Tyr Phe Ser Trp Lys Tyr Ser 135 140
His Arg Arg His His Ser Asn Thr Gly Ser 145 150
Leu Glu Arg Asp Glu Val Phe Val Pro Arg 155 160
Arg Ser Gln Thr Ser Ser Gly Thr Ala Ser 165 170
Thr Ser Thr Thr Phe Gly Arg Thr Val Met 175 180
Leu Thr Val aln Phe Thr Leu Gly Trp Pro 185 190
Leu Tyr Leu Ala Phe Asn Val Ser Gly Arg 195 200 Pro Tyr Asp Gly Gly Phe Ala Cys His Phe 205 210
His Pro Asn Ala Pro He Tyr Asn ASD Arg 215"220
Glu Arg Leu Gln He Tyr He Ser Asp Ala 225 230
Gly He Leu Wing Val Cys Tyr Gly Leu Leu 235 240
Pro Tyr Ala Ala Val Gln Gly Val Ala. Ser 245 'S0
Met Val Cys Phe Leu Arg Val Pro Leu Leu • 255 260 lie Val Asn Gly Phe Leu Val Leu He T r 265 270
Tyr Leu Gln His thr His Pro Ser Leu Pro 275 230
His Tyr Asp Being Ser Glu Trp Asp Trp Leu 285 290
Arg Gly Ala Leu Ala Thr Val Asp Arg Asp 295 300
Tyr Gly He Leu Asn Gln Gly Phe His Asn 305 310
He Thr Asp Thr His Glu Wing His His Leu 315 320
Phe Ser Thr Met Pro His Tyr His Ala Met 325 330
Glu Ala Thr Lys Ala He Lys Pro lie Leu 335 340
Gly Glu Tyr Tyr Gln Phe Asp Gly Thr Pro 345 350
Val Val Lys Ala Met Trp Arg Glu Ala Lys 355 360
Glu Cys He Tyr Val slu Pro Asp Arg Gln 365 370 Gly Glu Lys Lys Gly Val Phe Trp Tyr Asn 375 380 Asn Lys Leu Xaa
ORMATION FOR SEQ ID NO: 8:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 390 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 8
* *
Being Leu Leu Thr Being Phe Being Tyr Val Val 5 10 Tyr Asp Leu Being Phe Wing Phe He Phe Tyr 15 20 He Wing Thr Thr Tyr Phe His Leu Leu Pro 25 30 Gln Pro Phe Ser Leu He Wing Trp Pro He 35 40 Tyr Trp Val Leu Gln Gly Cys Leu Leu Thr 45 50 Arg Val Cys Gly His His Wing Phe Ser Lys 55 60 Tyr Gln Trp Val Asp Asp Val Val Gly Leu 65 70 Thr Leu His Ser Thr Leu Leu Val Pro Tyr 75 80 Phe Ser Trp Lys He Ser His Arg Arg His 85 90 His Ser Asn Thr Gly Ser Leu Asp Arg Asp 95 100 Glu Arg Val Lys Val Wing Trp Phe Ser Lys 105 110 Tvr Leu Asn Asn Pro Leu Gly Arg Wing Val 115 120
* *
Be Leu Leu Val Thr Leu Thr He Gly Trp 125 130 Pro Met Tyr Leu Wing Phe Asn Val Ser Gly 135 1 0 Arg Pro Tyr Asp Ser Phe Wing Ser His Tyr '145 iso His Pro Tyr Arg Val Arg Leu Lßu He Tyr 155 160 Val Ser Asp Val Ala Leu Phe Ser Val Thr 165 170 Tyr Ser Leu Tyr Arg Val Wing Thr Leu Lys 175 180 Gly Leu Val Trp Leu Leu Cys Val Tyr Gly 185 190 Val Pro Leu Leu He Val Asn Gly Phe Leu 195 200 Val Thr He Thr Tyr Leu Arg Val His Tyr 205 210 Asp Ser Ser Glu Trp Asp Trp Leu Lys Gly 215 220 Wing Leu Wing Thr Met Asp Arg Asp Tyr Gly 225 230 He Leu Asn Lys Val Phe His His He Thr 235 240 Asp Thr His Val Wing His His Leu Phe Ser 245 250 Thr Met Pro His Tyr His Leu Arg Val Lys 255 260 Pro He Leu Gly Glu Tyr Tyr Gln Phe Asp 265 270 Asp Thr Pro Phe Tyr Lys Ala Leu Trp Arg 275 280 Glu Ala Arg Glu Cys Leu Tyr Val Glu Pro 285 290 Asp Glu Gly Thr Ser Glu Lys Gly Val Tyr 295 300 Trp Tyr Arg Asn Lys Tyr Leu Arg Val 305
ORMATION FOR SEQ ID NO: 9:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 302 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 9:
Phe Ser Tyr Val. Val Tyr Asp Leu Thr He 5 10
Wing Phe Cys Leu Tyr Tyr Val Wing Thr His 15 20
Tyr Phe His Leu Leu Pro Gly Pro Leu Ser 25 30
Phe Arg Gly Met Wing He Tyr Trp Wing Val 35 40
Gln Gly Cys He Leu Thr Gly Val Trp Val 45 50
Val Ala Phe Ser Asp Tyr aln Leu Leu Asp 55 60
Asp He Val Gly Leu He Leu His Ser Wing 65 70
Leu Leu Val Pro Tyr Phe Ser Trp Lys Tyr 75 80
Ser His Arg Arg His His Ser Asn Thr Gly 85 90
Ser Leu Glu Arg Asp Glu Val Phe Val Pro 95 100
Lys Val Ser Lys Tyr Leu Asn Asn Pro Pro IOS 110
Gly Arg Val Leu Thr Leu Wing Val Thr Leu 115 120
Thr Leu Gly Trp Pro Leu Tyr Leu Ala Leu 125 130
Asn Val Ser Gly Arg Pro Tyr Asp Arg Phe 135 140
Ala Cys His Tyr Asp Pro Tyr Gly Pro He 145 150
Tvr Ser Val He Ser Asp Wing Gly Val Leu 155 ISO
Wing Val Val Tyr Gly Leu Phe Arg Leu Wing 165 170
Met Ala Lys Gly Leu Ala Trp Val Val Cys • 175 13 °
Val Tvr Gly Val Pro Leu Leu Val Val Asn
Glv Phe Leu Val Leu He Thr Phe Leu Gln 1 3_95 200
His Thr His Val Ser Glu Trp Asp Trp Leu 205 210
Arg Gly Ala Leu Ala Thr Val Asp Arg Asp 215 220
Tyr Gly He Leu Asn Lys Val Phe His sn 1 22S 230
He Thr Asp thr His Val Wing His His L u 235 240
Phe Ser thr Met Pro His Tyr His Ala Met 245 25 °
Glu Ala Thr Val Glu Tyr Tyr Arg Phe Asp 255 260
Glu Thr Pro Phe Val Lys Wing Met Trp Arg 265 2 / u
Glu Ala Arg Glu Cys He Tyr Val Glu Pro
Asp Gin Ser thr Glu Ser Lys Gly Val Phe 285 Trp Tyr Asn Asn Lys Leu Wing Met Glu Wing 295 300 Thr Val
ORMATION FOR SEQ ID NO: 10:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 372 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 10
Met Gly Wing Gly Gly Arg Met Thr Glu Lys 5 10
Glu Arg Glu Lys Gln Glu Gln Leu Arg Wing 15 20
Wing Thr Gly Gly Wing Wing Met Gln Arg Ser 25 30
Pro Val Glu Lys Pro Pro Phe Thr Leu Gly 35 40.
Gln He Lys Lys Wing Pro Pro His Cys 45 50
Phe Glu Arg Ser Val Leu Lys Ser Phe Ser 55 60
Tyr Val Val His Asp Leu Val He Wing Wing 65 70
Ala Leu Leu Tyr Phe Ala Leu Ala He He 75 80
Pro Ala Leu Pro Ser Pro Leu Arg Tyr Ala 85 90
Wing Trp Pro Leu Tyr Trp He Wing Gln Gly 95 100
Wing Phe Ser Asp Tyr Ser Leu Leu Asp Asp 105 110
Val Val Gly Leu Val Leu His Ser Ser Leu 115 120
Met Val Pro Tyr Phe Ser Trp Lys Tyr Ser 125 130
His Arg Arg His His Ser Asn Thr Gly Ser 135 140
Leu Glu Arg Asp Glu Val Phe Val Pro Lys 145 150
Lys Lys Glu Ala Leu Pro Trp Tyr Thr Pro 155 160
Tyr Val Tyr Asn Asn Pro Val Gly Arg.Val 165 170
Val His He Val Val Gln Leu Thr Leu Gly .175 180
Trp Pro Leu Tyr Leu Wing Thr Asn Wing Ser 185 190
Gly Arg Pro Tyr Pro Arg Phe Ala Cys His 195 200
Phe Asp Pro Tyr Gly Pro He Tyr Asn Asp 205 210
Arg Glu Arg Ala Gln He Phe Val Ser Asp 215 220
Wing Gly Val Val Wing Val Wing Phe Gly Leu 225 230
Tyr Lys Leu Wing Wing Wing Phe Gly Val Trp 235 240
Trp Val Val Arg Val Tyr Ala Val Pro Leu 245 250
Leu He Val Asn Ala Trp Leu Val Leu He 255 260
Thr Tyr Leu Gln His Thr His Pro Ser Leu 265 270
Pro His Tyr Asp Ser Ser Glu Trp Asp Trp 275 280
Leu Arg Gly Ala Leu Ala Thr Met A3p Arg 285 290 Asp Tyr Gly He Leu Asn Arg Val Phe His 295 300
A = n He Thr Asp Thr His Val Wing His His 305 310
Leu Phe Ser thr Met Pro Hís Tyr His Ala 315 320
Met Glu Wing Thr Lys Wing He Arg Pro He 325 330 Leu Gly Asp Tyr Tyr His Phe Asp Pro Thr 335 340 Pro Val Wing Lys Wing Thr Trp Arg Glu Wing 345 350 Gly Giu Cys He Tyr Val Glu Pro Glu Asp 355 360 Arg Lys Gly Val Phe Trp Tyr Asn Lys Lys 365 370 Phe Xaa
ORMATION FOR SEQ ID NO: 11:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 224 amino acids (B) TYPE: amino acid (C) TYPE OF HEBRA: (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 11 Trp Val Met Wing His Asp Cys Giy His His 5 10
Wing Phe Ser Asp Tyr Gln Leu Leu Asp Asp 15 20
Val Val Gly Leu He Leu His Ser Cys Leu 25 30
Leu Val Pro Tyr Phe Ser Trp Lys His Ser 35 40
His Arg Arg His His Ser Asn Thr Gly Ser 45 50
Leu Glu Arg Asp Glu Val Phe Val Pro Lys 55 60
Lys Lys Ser Ser He Arg Trp Tyr Ser Lys 65 70
Tyr Leu Asn Asn Pro Pro Gly Arg He Met 75 80
Thr He Ala Val Thr Leu Ser Leu Gly Trp 85 90
Pro Leu Tyr Leu Wing Phe Asn Val Ser: Gly 95 100
Arg Pro Tyr Asp Arg Phe Ala Cys His Tyr 105 no
Asp Pro Tyr Gly Pro He Tyr Asn Asp Arg 115 120
Glu Arg He Glu He Phe He Ser Asp Ala 125 130
Gly Val Leu Ala Val Thr Phe Gly Leu Tyr 135 140
Gln Leu Ala He Ala Lys Gly Leu Ala Trp 145 150
Val Val Cys Val Tyr Gly Val Pro Leu. Leu 155 160
Val Val Asn Ser Phß Leu Val Leu He Thr 165 170
Phe Leu Gln His Thr His Pro Ala Leu Pro 175 180
His Tyr Asp Being Ser Glu Trp Asp Trp Leu 185 190
Arg Gly Ala Leu Ala Thr Val Asp Arg Asp 195 200
Tyr Gly He Leu Asn Lys Val Phe His Asn 205 210
He Thr Asp Thr Gln Val Wing His His Leu 215 220 Phe Thr Met Pro 2) INFORMATION FOR SEQ ID NO: 12: (i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 20 nucleotides (B) TYPE: nucleotide (C) ) TYPE OF HEBRA: simple (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 12
GCTCTTTTGT GCGCTCATTC 20
2) INFORMATION FOR SEQ ID NO: 13:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 20 nucleotides (B) TYPE: nucleotide (C) 'TYPE OF HEBRA: simple (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 13: CGGTACCAGA AAACGCCTTG 20 2) INFORMATION FOR SEQ ID NO: 14:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 20 nucleotides (B) TYPE: nucleotide (C) TYPE OF HEBRA: simple (D) TOPOLOGY: linear
(xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 14:
TAYWSNCAYM GNMGNCAYCA 20
2) INFORMATION FOR SEQ ID NO: 15:
(i) CHARACTERISTICS OF THE SEQUENCE: (A) LENGTH: 21 nucleotides (B) TYPE: nucleotide (C) TYPE OF HEBRA: simple (D). TOPOLOGY: linear (xi) DESCRIPTION FOR THE SEQUENCE: SEQ. ID No: 15: RTGRTGNGCN ACRRTGNGTRT C 21
It is noted that in relation to this date, the best method known by the applicant to carry out the present invention is that which is clear from the present description of the invention.
Having described the invention as above, the content of the following is claimed as property:
Claims (34)
1. A method for altering an amount of an unsaturated fatty acid in a seed of a plant, characterized in that it comprises: decreasing the activity of a fatty acid-desaturase in the seed by genetic manipulation in at least one of the fatty acid-desaturase or fatty acid-hydroxylase.
2. The method according to claim 1, characterized in that an endogenous gene of the fatty acid hydroxylase is mutated and thus decreases the activity of the fatty acid hydroxylase in the seed.
3. The method according to claim 1, characterized in that the plant is transformed with a nucleic acid containing a sequence coding for a fatty acid-hydroxylase or derivative thereof.
4. The method according to claim 3, characterized in that the derivative is a dominant negative mutant which thereby alters the amount of the unsaturated fatty acid in the seed.
5. The method according to claim 3, characterized in that the derivative is a mutant fatty acid-hydroxylase in which one or more essential histidine residues have been mutated, which thereby alters the amount of the saturated fatty acid in the seed .
6. The method according to claim 1, characterized in that an endogenous gene for the fatty acid desaturase is mutated and thereby decreases the activity of the fatty acid-desaturase in the seed.
7. The method according to claim 1, characterized in that the plant is transformed with a nucleic acid containing a sequence coding for a fatty acid-desaturase or derivative thereof.
8. The method according to claim 7, characterized in that the derivative is a dominant negative mutant which thus alters the amount of the unsaturated fatty acid in the seed.
9. The method according to claim 7, characterized in that the derivative is a mutant fatty acid-desaturase in which one or more essential histidine residues have been mutated, thereby altering the amount of the unsaturated fatty acid in the seed.
10. The method according to claim 1, characterized in that the plant is sucked from the group consisting of naba, Cra be, Brassica júncea, cañola, flax, sunflower, safflower, cotton, cuphea, soybean, peanut, coconut, palm oil and corn
11. A method for altering an amount of an unsaturated fatty acid, characterized in that it comprises: (a) transforming a plant cell with a nucleic acid containing a sequence encoding a fatty acid-hydroxylase or a negative, dominant mutant of the acid -hydroxylase-fat or a negative, dominant mutant of the fatty acid-desaturase. (b) cultivate a plant that has seeds from the transformed plant cell of step (a), and (c) identifying a seed of the plant of step (b) with the altered amount of unsaturated fatty acid and seed.
12. The method according to claim 11, characterized in that the nucleic acid contains a sequence coding for the negative, dominant mutant of the fatty acid-hydroxylase in which one or more essential histidine residues have been mutated.
13. The method according to claim 11, characterized in that the nucleic acid contains a sequence coding for the dominant negative of the fatty acid-hydroxylase which thus alters the amount of the unsaturated fatty acid in the seed.
14. The method according to claim 11, characterized in that the nucleic acid contains a sequence coding for the negative, dominant mutant of the fatty acid-desaturase in which one or more essential histidine residues has been mutated.
15. The method according to claim 11, characterized in that the nucleic acid contains a sequence coding for the negative, dominant mutant of the fatty acid-desaturase which thereby alters the amount of the unsaturated fatty acid in the seed.
16. The method according to claim 11, characterized in that the plant is selected from the group consisting of naba, Cra be, Brassica júncea, cañola, flax, sunflower, safflower, cotton, cuphea, soybean, peanut, coconut, palm oil and corn
17. A recombinant nucleic acid according to the use of claim 1, characterized in that the nucleic acid contains a sequence coding for a fatty acid-hydroxylase with an amino acid entity of 60% greater than SEQ ID NO: 4.
18. The recombinant nucleic acid according to claim 17, characterized in that the amino acid identity is 90% or greater than SEQ ID NO: 4.
19. The recombinant nucleic acid according to claim 17, characterized in that the amino acid identity is 100% of SEQ ID NO: 4.
20. The recombinant nucleic acid according to claim 17, characterized in that the nucleic acid contains a sequence having a nucleotide identity of 90% greater than SEQ ID NO: 1, 2 or 3.
21. The reccmbinant nucleic acid according to claim 17, characterized in that the nucleic acid contains SEQ ID NO: 1, 2 or 3.
22. The recombinant nucleic acid according to claim 17, characterized in that the sequence can be obtained from a plant sequence that produces a hydroxylated fatty acid.
23. A recombinant nucleic acid according to the use in claim 1, characterized in that the nucleic acid contains a sequence coding for at least one fatty acid-desaturase or a fatty acid-hydroxylase.
24. The recombinant nucleic acid according to claim 23, characterized in that the sequence can be obtained from Ricinus communis (L.) (castor).
25. The recombinant nucleic acid according to claim 23, characterized in that the sequence can be obtained from Lesquerella fendleri.
26. The recombinant nucleic acid according to claim 23, characterized in that the nucleic acid contains a sequence that * codes for at least one of fatty acid-desaturase or fatty acid-hydroxylase in which one or more histidine residues have been mutated essentials
27. The method according to claim 1, characterized in that it further comprises: processing the seed containing the altered amount of unsaturated fatty acid to obtain the oil and / or seed feed.
28. The oil characterized in that it can be obtained by the method of claim 27.
29. The seed food characterized in that it is obtained by the method of claim 27.
30. The plant characterized in that it is obtained by the method of claim 1.
31. The method according to claim 11, characterized in that it further comprises: processing the seed containing the altered amount of unsaturated fatty acid to obtain oil and / or seed feed.
32. The oil characterized in that it obtains per the method of claim 31.
33. The seed food, characterized in that it is obtained by the method of claim 31.
34. The plant characterized in that it is obtained by the method of claim 11.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08597313 | 1996-02-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA98006317A true MXPA98006317A (en) | 1999-09-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU723161B2 (en) | Alteration in an amount of an unsaturated fatty acid by genetic manipulation | |
US6433250B1 (en) | Use of plant fatty acyl hydroxylases to produce hydroxylated fatty acids and derivatives in plants | |
US5668292A (en) | Use of plant fatty acyl hydroxylases to produce hydroxylated fatty acids and derivatives in plants | |
CA2087977A1 (en) | Plant fatty acid synthases | |
EP1206558A2 (en) | Plants with modified polyunsaturated fatty acids | |
US6825335B1 (en) | Synthetic fatty acid desaturase gene for expression in plants | |
US6291742B1 (en) | Production of hydroxylated fatty acids in genetically modified plants | |
US6501004B1 (en) | Transgenic reduction of sinapine in crucifera | |
MXPA98006317A (en) | Production of hydroxyled fatty acids in plants genetically modifies | |
WO1999053073A9 (en) | Interconversion of plant fatty acid desaturases and hydroxylases | |
Napier et al. | Method For The Production Of Gamma-linolenic Acid And/or Stearidonic Acid In Transgenic Brassicaceae And Linaceae (Patent US 2008/0229454 A1) | |
AU2004200281A1 (en) | Interconversion of plant fatty acid desaturases and hydroxylases |